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ABSTRACT 
IDENTIFYING REGULATION OF CANT1 
DURING ENDOPLASMIC RETICULUM STRESS-INDUCED CELL DEATH 
 
Öznur Aktay 
Molecular Biology, Genetics and Bioengineering, M.Sc. Thesis, July 2018 
Thesis Supervisor: Prof. Dr. Hüveyda Başağa 
 
Keywords: CANT1, ER stress, cell death, breast cancer  
 
Calcium-activated nucleotidase 1 (CANT1) is a member of apyrase family of enzymes which 
are responsible for hydrolysis of extracellular nucleoside tri-phosphate and di-phosphate to 
nucleoside monophosphates. The mutation in CANT1 gene causes an autosomal recessive 
disorder known as Desbuquois dysplasia, revealing skeletal growth abnormalities. CANT1 
is an endoplasmic reticulum (ER)-resident protein so that previous studies have suggested 
roles for CANT1 which are related to ER functions and mechanisms such as protein quality 
control or unfolded protein response. The first CANT1 expression study in cancer has 
emerged in prostate cancer research due to the high expression level of CANT1 in prostate 
tissue. In this study, we aimed to identify the regulation of CANT1 expression during ER 
stress-activated cell death in breast cancer cell lines MCF7, SK-BR-3, and MDA-MB-468. 
We induced ER stress-related cell death by Thapsigargin and investigated how the protein 
expression, mRNA level and subcellular localization of CANT1 change in breast cancer cell 
lines. Immunoblot results indicate that CANT1 protein expression was altered during ER 
stress while we did not observe any change in CANT1 mRNA level. Additionally, subcellular 
localization of CANT1 protein upon ER stress was detected by laser scanning confocal 
microscope and we obtained increasing colocalization of CANT1 protein with ER but not 
with mitochondria. Here, first time, we reported how CANT1 expression levels and its 
subcellular localization change in breast cancer cells upon drug-mediated ER stress-induced 
cell death.
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ÖZET 
ENDOPLAZMİK RETİKULUM STRESİ İLE İLGİLİ HÜCRE ÖLÜMÜNDE  
CANT1 REGÜLASYONUNUN TANIMLANMASI 
 
Öznur Aktay 
Moleküler Biyoloji, Genetik ve Biyomühendislik, Yüksek Lisans Tezi, Temmuz 2018 
Tez Danışmanı: Prof. Dr. Hüveyda Başağa 
 
Anahtar kelimeler: CANT1, ER stresi, hücre ölümü, meme kanseri 
CANT1, apiraz enzim ailesine mensup, hücre dışındaki nükleozit tri- ve di-fosfatın nükleozit 
monofosfata hidrolizinden sorumlu bir enzimdir. CANT1 genindeki mutasyon otozomal 
çekinik bir hastalık olarak bilinen ve iskelet gelişiminde anormalliklere yol açan Desbuquois 
displazisine sebep olur. CANT1 endoplazmik retikulum (ER) yerleşik bir protein olduğu için, 
yapılan çalışmalar CANT1 için ER fonksiyon ve mekanizmaları ile ilgili protein kalite 
kontrolü ve katlanmamış protein cevabı gibi roller önermektedir. Prostat dokusunda CANT1 
anlatımının yüksek seviyede olmasından dolayı, kanser konseptinde, CANT1 proteini ilk 
olarak prostat kanserinde araştırılmıştır. Bu çalışma ile, ER stresiyle aktifleştirilmiş hücre 
ölümü sırasında CANT1 anlatımının meme kanseri hücre hatlarındaki (MCF7, SK-BR-3 ve 
MDA-MB-468) regülasyonunu tanımlamayı hedefledik. Thapsigargin kullanarak, ER 
stresiyle ilgili hücre ölümünü aktifleştirdik ve meme kanseri hücre hatlarında CANT1’in 
protein anlatımının, mRNA seviyesinin ve hücre içi lokalizasyonunun nasıl değiştiğini 
araştırdık. İmmünoblot sonuçları ER stresi esnasında CANT1 proteininin anlatımının 
değiştiğini ortaya koyarken, mRNA seviyesinde bir değişiklik gözlemlenmedi. Bunlara ek 
olarak, CANT1 proteininin hücre içindeki lokalizasyonunu lazer taramalı konfokal 
mikroskobu ile saptadık ve CANT1 proteininin ER stresine bağlı olarak ER ile 
kolokalizasyonunun arttığı, fakat mitokondri ile kolokalizasyonunda herhangi bir değişim 
olmadığı sonucunu elde ettik. Bu çalışmada, ilk defa, ilaç kontrollü ER stresiyle uyarılmış 
hücre ölümünde, CANT1 anlatım seviyelerinin ve hücre içi lokalizasyonlarının nasıl 
değiştiğini göstermiş olduk. 
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1. INTRODUCTION 
1.1.  Endoplasmic Reticulum 
Endoplasmic reticulum (ER) is a central organelle which consists of sacs and tubes forming 
a labyrinth-shaped compartment enclosed by lipid bilayer. ER system has major roles in the 
cell such as regulation of protein and lipid processing, protein folding and quality control, 
post-translational modification of proteins and calcium storage 1. 
Protein processing takes place in ER lumen. Most proteins are directed to ER with a signal 
peptide sequence. This signal is comprised of approximately first 25 amino acids of a 
protein2. Once a signal is recognized and protein is translocated to ER lumen, protein folding 
machinery conducts properly folding of proteins with helper proteins called chaperones and 
folding enzymes. Besides being responsible for proper folding of proteins, chaperones 
prevent aggregation in ER to provide a cleaned-up environment for protein folding 3.  
Protein modification step is required to obtain a mature protein. Co-translational and post-
translational protein modification mechanisms in ER includes N-glycan addition and 
disulfide bond formation 4. Oligosaccharide side chain addition to protein assists to keep its 
native polypeptide structure stabile, so that it prevents formation and aggregation of 
misfolded proteins 3. Asparagine-linked carbohydrates are involved in quality control 
mechanisms of ER for unfolded and misfolded proteins. UDP-glucose:glycoprotein–
glucosyltransferase (UGGT) is able to detect incomplete folding of glycoproteins and it re-
glycosylates them until completing protein folding correctly 5. Disulfide bond formation 
occurs when two cysteine residues covalently bind to each other and this event is monitored 
by protein disulfide isomerase (PDI) enzyme family in ER. As a post-translational 
modification, formation of disulfide bonds enhances the stability of polypeptide chain 6.  
ER quality control procedure relies on checking protein folding, assembling and 
modification. Successfully folded mature proteins pass from ER quality control and they are 
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allowed to leave ER through the secretory pathway. However incompletely folded or 
misfolded proteins are not secreted from ER and they are directed to retention and 
degradation 7. 
Lipid biosynthesis, another important feature of ER, takes place in the endomembrane 
compartment which consists of ER and Golgi apparatus. Synthesized lipids are transferred 
to other organelles or cell surface via secretory pathway 8.  
Majority of intracellular calcium is stored in ER. Calcium homeostasis in ER is maintained 
by Ca2+ -ATPase pumps. High concentration of Ca2+ in ER lumen is required for proper 
folding 3. 
1.2.  ER Stress 
1.2.1. Unfolded Protein Response (UPR)  
Aggregation of misfolded proteins, calcium imbalance, nutrient deprivation, hypoxia, change 
in pH, oxidative stress and infections can disrupt ER homeostasis and they cause ER stress. 
The defense mechanism against ER stress conditions is called unfolded protein response 
(UPR) 9. Activation of the cellular response through stress conditions is vital for deciding 
cell fate. UPR mediates the reestablishment of ER homeostasis by degrading misfolded 
proteins to clean ER lumen in order to reinforce the efficiency of protein folding machinery. 
In the case of ER homeostasis is not restored, stress signaling induces the expression of pro-
death genes to execute cell death 10. 
To activate UPR signaling, ER stress detection is required. UPR mechanism consists of 
chaperones and ER-resident sensors to recognize ER stress elements and to carry out 
downstream signaling. 
1.2.1.1. Initiation of UPR signaling 
ER chaperons and ER-embedded transducers of UPR signaling cooperate to sense misfolded 
or unfolded proteins. ER-resident chaperone BiP/Grp78 (immunoglobulin heavy chain 
binding protein/glucose- regulated protein 78 kDa molecular weight) is a member of heat-
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shock protein (HSP) family. It sequesters nascent polypeptides while polypeptide synthesis 
continues. BiP chaperone has two domains, ATPase binding site at its N-terminal and 
substrate-binding domain at C-terminal. ATPase activity of BiP is induced when BiP binds 
to a polypeptide. Nucleotide exchange in BiP causes a reduction in the binding affinity of 
BiP to its substrate. ATP hydrolysis is required to increase the rate of BiP-polypeptide 
interaction affinity 11.  
BiP is found to be interacted to three ER-transmembrane proteins, ATF6 (activating 
transcription factor 6), PERK (protein kinase RNA-like endoplasmic reticulum kinase), and 
IRE1 (inositol-requiring enzyme 1) and keep them inactive in unstressed environment. 
Initiation of UPR signaling is followed by the disassembly of BiP from ER-transmembrane 
sensors. Once unfolded proteins are accumulated in ER lumen, BiP dissociates from three 
ER stress sensors to hold accumulated proteins in the lumen. Thus, BiP unblocks the ER 
stress sensors and facilitates their activation of by releasing them 10. 
1.2.1.2. Downstream of UPR execution 
Stress response signaling is generated to determine the fate of cell that exposed to stress. The 
result of downstream signaling can be either restoring ER homeostasis or directing the cell 
to death 12. ER-transmembrane proteins ATF6, PERK and IRE1 can operate UPR signaling 
(Figure 1.1) by inducing pro-survival or pro-death genes according to the reflection of ER 
stress. If the damage that caused by stress is too severe to maintain survival of cell, then 
apoptosis is activated to prevent malfunctioning. In the other scenario, if the accumulation 
rate of misfolded and unfolded proteins is not excessive, UPR signaling contributes to cell 
survival. 
1.2.1.2.1 ATF6 
ATF6 (activating transcription factor 6) is a type-II transmembrane protein that is positioned 
its C-terminal at lumen of ER and N-terminal at cytosol. There are two isoforms of ATF6 in 
mammals, ATF6α and ATF6β 13. 
When ATF6 is activated by BiP dissociation, it translocates from ER to the Golgi to be 
cleaved by site-1 protease (S1P) and site-2 protease (S2P), respectively 14.  
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Figure 1.1. Three ER-resident proteins that execute unfolded protein response. ATF6, 
PERK and IRE1 are the sensors of UPR signaling. In unstressed environment, BiP has an 
interaction with ER transmembrane sensors. Accumulated unfolded proteins recruits BiP 
chaperon to ER lumen so that the sensors are released and activated. ATF6 is translocated to 
the Golgi to be cleaved and then ATF6(N) moves into nucleus to induce its target genes. 
After releasing from BiP, PERK dimerizes and auto-phosphorylates itself and the eukaryotic 
translational initiation factor eIF2α. Phosphorylation of eIF2α activates the expression of 
ATF4, which regulates its targets XBP1 and CHOP. Oligomerization and auto-
phosphorylation is also observed in IRE1. Upon its activation, one branch of IRE1 signaling 
is involved in splicing of XBP1 mRNA. This splicing enhances XBP1’s transcriptional 
activity that has an effect to reconstruct ER homeostasis. Alternatively, IRE1 is associated 
with initiation of cell death either by interacting pro-apoptotic elements of death pathway or 
JNK (c-Jun-N-terminal kinase) signaling 15. 
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Cleavage of ATF6 is processed through its N-terminus which contains bZIP (basic leucine 
zipper motif) transcription factor domain. This cytoplasmic domain (N-ATF6) then migrates 
into nucleus to activate transcription of genes that are related to ER stress regulation such as 
ER chaperones and ERAD (ER-associated degradation) proteins. The genes that ATF6 
targets are BiP/GRP78, GRP94 (glucose-regulated protein 94), XBP1 (X-box binding protein 
1), CHOP (transcription factor C/EBP homologous protein, also named GADD153),  and 
PDI 12, 14. 
1.2.1.2.2 PERK 
Another UPR pathway executer is PERK (protein kinase RNA-like endoplasmic reticulum 
kinase) which is a type-I ER transmembrane protein. PERK is known as a serine/threonine 
kinase 16. Upon disengage from BiP, PERK dimerizes and auto-phosphorylates itself to 
initiate and conduct stress respond signaling 12.  
Active PERK phosphorylates the eukaryotic translational initiation factor eIF2α. 
Phosphorylation of eIF2α reduces the rate of global translation, and this reduction assists to 
gain ER homeostasis back in terms of preventing more aggregation by effecting the rate of 
protein transfer into ER. However selective translation can take place during translational 
blockage. ATF4 (activating transcription factor 4) mRNA translation is one example of 
selective translation 17. ATF4 is a transcription factor that mainly regulates the transcription 
of its target genes GADD34 (growth arrest and DNA damage-induced transcript 34), XBP1 
and CHOP 18. Expression of CHOP controls the activation of pro-death genes 19, 20 while it 
also can inhibit the expression of anti-apoptotic protein Bcl-2 (B-cell lymphoma 2) 21.  
1.2.1.2.3 IRE1 
IRE1 (inositol requiring enzyme 1) is the third member of ER transmembrane sensors. It is a 
type-I transmembrane protein that has serine/threonine kinase domain and endoribonuclease 
domain. IRE1α and IRE1β are mammalian homolog forms of IRE1p which is synthesized in 
yeast 22. 
Under stress conditions, after IRE1 dissociates from BiP, it oligomerizes and activates kinase 
and RNase domains by auto-phosphorylation 23. Once it is activated, endoribonuclease 
domain of IRE1 cleaves its target mRNA XBP1, and causes a frameshift that generates bZIP 
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transcription activation of XBP1. As a transcription factor, XBP1 is responsible for 
expression of the genes that mediate the recovery of ER homeostasis. XBP1 enhances ER 
protein folding capacity by leading expression of ER chaperones and ERAD proteins 24. 
Regulated IRE1-dependent mRNA decay (RIDD) is an adaptive mechanism in which ER-
related mRNAs are degraded 25. Removal of ER-related mRNAs by RIDD manages the 
workload of ER to allow ER to function efficiently. This case explains the role of RIDD in 
supporting cell survival. However, extended and continuous RIDD processing can induce 
pro-apoptotic genes and causes cell death 26.  IRE1 also contributes to JNK (c-Jun-N-terminal 
kinase) pathway-linked cell death 27. 
1.2.2. Pharmacological Inducers of ER Stress 
1.2.2.1. Thapsigargin 
Thapsigargin (THG) is a plant-originated chemical compound that belongs to sesquiterpene 
lactones group 28.  
The biological role of Thapsigargin is to inhibit the sarcoplasmic or endoplasmic 
(sarco/endoplasmic) reticulum calcium-ATPase (SERCA) family pumps which are 
responsible for the transfer of cytosolic Ca+2 ions into their storage compartment ER 29. 
Inhibited SERCA activity causes Ca+2 leakage and, consequently, Ca+2 depletion in ER. 
Since ER Ca+2 homeostasis is disrupted by blocking the SERCA, it induces ER stress that 
resulting cell death. Interaction of Thapsigargin and SERCA is mediated by a lipophilic 
approach 28. X-ray structure analysis revealed that side chains of Thapsigargin penetrate 
alpha-helix structures of SERCA. Upon binding covalently, the blocked pump is not able to 
change its conformation to transport Ca+2 ions actively 30.  
 
 
 
 
Figure 1.2. Structure of Thapsigargin (Adapted from reference 28) 
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SERCA in humans is encoded by three genes: SERCA1, SERCA2 and SERCA3. Additionally, 
SERCA has isoforms that obtained by alternative splicing 31. Thapsigargin can act on all 
isoforms of SERCA 29. On the other hand, it is previously reported that several established 
Thapsigargin analogues differently but effectively inhibit the enzymatic activity of SERCA 
32, 33. 
Since Thapsigargin exposed cells undergo apoptotic cell death, Thapsigargin is thought to be 
used as a therapeutic agent that targeting certain cancer types. For this purpose, prodrugs 
were generated by attaching Thapsigargin to specific peptide groups. Thus, designed prodrug 
becomes active only in certain cancer cells due to its specific affinity 30, 34, 35. 
1.2.2.2. Other chemical inducers 
Various chemicals target ER function to disrupt its homeostasis through interfering different 
components of ER. 
Tunicamycin is one of the widely used ER stress inducers. It is an antibiotic and it is produced 
in bacteria named Streptomyces lysosuperificus 36. Tunicamycin behaves as an inhibitor of  
asparagine-linked glycosylation which is an important step of protein quality control 
mechanism in ER 37. The other chemical agent that has an inhibitory effect on N-linked 
glycosylation is 2-deoxy-D-glucose (2DG) 38. 
Calcium ionophores ionomycin and A-23187 causes the increase of cytosolic Ca+2 level by 
carrying luminal Ca+2 from ER to cytosol. Then, ER becomes Ca+2-deficient and ER stress 
is induced 39. 
Brefeldin A (BFA) prevents proteins to be transported from ER to the Golgi through the 
secretory pathway, and accumulation of proteins in ER causes ER stress 40. 
One group of chemical ER stressors are the reducing agents β-Mercaptoethanol (2-
Mercaptoethanol, BME) and Dithiothreitol (DTT) 39. They restrict disulfide bond formation 
between two cysteine residues during protein folding. Finally, unfolded proteins triggers ER 
stress. 
Other chemical agents that induce ER stress are Geldanamycin and Bortezomib. 
Geldanamycin inhibits the function  of  HSP90 (Heat shock protein 90), and the proteasome  
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inhibitor Bortezomib is used as an anti-tumor medication that is commercially available 39. 
1.3.  Mode of ER Stress in Cancer 
Studies have elucidated the relation between ER stress and cancer. In cancer, to gain ER 
homeostasis back by the adaptive mechanism UPR is considered as maintaining a suitable 
environment for cell survival and growth 41. Hypoxia, lack of nutrient, changes in pH, 
insufficient vascularity are stress conditions that restrict the growth of tumor cells and these 
stress conditions induce UPR in cancer. During tumor development, cancer cells need rapid 
and active cellular mechanisms to proliferate highly. Requirements for increased growth rate 
are advanced protein folding, modification and transportation which take place in ER. 
Unexpected increase in these cellular events causes ER stress, however the response to ER 
stress conditions has mainly a protective role for cancer cells 42, 43.  
UPR sensor proteins (ATF6, PERK and IRE1), their collaborator chaperone proteins and 
downstream elements of UPR control tumor development through various aspects. Initiation 
of tumorigenesis, supporting cell growth, proliferation and survival, activation of anti-
apoptotic mechanisms, regulation of metastasis and invasiveness, and establishment of 
angiogenesis are examples of how UPR agents involve in the management of cancer 
development. The high number of ER stress mechanism members in cancer progression 
offers a wide range of target for anti-cancer therapy. 
The major ER chaperone BiP/Grp78 is overexpressed in several cancer types including breast 
cancer 44, pancreatic cancer 45, colorectal cancer 46, gastric cancer 47, renal cell carcinoma 48, 
glioblastoma 49 and ovarian cancer 50. It is reported that BiP/Grp78 is required to mediate 
tumor development, cell survival and angiogenesis 51. BiP/Grp78 also plays an important role 
in metastasis and drug-resistance mechanisms 47. In colorectal cancer, expression of 
BiP/Grp78 is associated with response to chemotherapy 46. In addition, the invasiveness of 
hepatocellular carcinoma is triggered by BiP 41. 
Activation of ATF6 controls tumor progression specifically through metastasis and invasion 
mechanisms of cancer 52. In the dormant state of carcinomas, transcription factor ATF6α 
supports tumor cell survival by activating Rheb (Ras homolog, mTORC1 binding)-mTOR 
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signaling 53.  One recent study revealed that high ATF6 expression was detected in atypically 
changing lesions of colorectal cancer 54. Another study showed that the enhanced survival of 
glioblastomas was supported by an ATF6 regulated mechanism 55.  
The role of PERK in cancer cell proliferation and tumor growth is mostly controlled through 
its downstream elements eIF2α and ATF4. PERK/ATF4 signaling sustains angiogenesis 
mechanism to enrich vascularization in tumor microenvironment for proliferation of tumors. 
ATF4 directly binds to the promoter of VEGF (Vascular endothelial growth factor) and 
activates the expression of VEGF to increase vascularity 56. Under hypoxic stress in breast 
cancer cells, ATF4 involves in the regulation of autophagy to promote cell survival against 
apoptotic cell death 57. The eIF2α-dependent branch of PERK activation controls autophagy 
induction in carcinomas 58. It is also reported that eIF2α regulates and supports metastasis 
under hypoxia 59. CHOP is one of the ATF4 target genes that is expressed upon UPR 
activation through PERK pathway. Upregulation of CHOP is detected in hepatocellular 
carcinoma, and it is also shown that CHOP promotes liver tumorigenesis 60.  
The third UPR sensor protein IRE1 has also significant effect on tumorigenesis. 
Transcription factor  XBP1, the downstream target of IRE1, is highly active in several human 
cancer types such as breast cancer 61, pancreatic 62 and hepatocellular carcinoma 63. XBP1 
involves in the tumorigenicity of triple-negative breast cancer through the HIF1α (Hypoxia-
inducing factor 1α) pathway 64. In one study, inactivation of XBP1 splicing in multiple 
myeloma was suggested as a promising therapeutic option 65. In addition to these, it has been 
reported that IRE1α is able to control cell proliferation in prostate cancer by regulating Cyclin 
A1 level and expression of ER-associated survival elements 66. In colon cancer, the inhibition 
of IRE1α affects colonic tumorigenesis negatively 67. Targeting IRE1α-XBP1 signaling in 
tumors proposes therapeutic approaches against tumorigenesis 62, 68.  
Other chaperone proteins that contributes to UPR mechanism are also associated to cancer 
mechanisms. HSP90 can interact with anti-tumorigenic element p53 and can allow cancer 
cells to grow and survive 69. HSP90 isoform Grp94 is related to metastasis and the inhibition 
of Grp94 by small molecules provides a method to treat aggressive and metastatic cancer 70. 
In multiple myeloma cells, deficient Grp94 induces apoptosis, and the same deficiency in a 
murine xenograft model prevents the growth of myeloma 71. 
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UPR elements also control the genomic instability, one of the hallmarks of cancer. It was 
indicated that inactivation of yeast homolog of IRE1 promotes genomic instability. 
Deficiency in the expression PERK is also able to trigger genomic instability in mammary 
carcinoma 52.  
1.4.  ER Stress-Mediated Cell Death 
UPR is thought as a survival mechanism since it is mostly engaged to gaining ER homeostasis 
back to provide suitable conditions for ER to function properly. If a cell is exposed to 
prolonged ER stress and UPR cannot restore ER homeostasis, cell death mechanisms are 
activated to direct the cell to death. Apoptosis and autophagy are cell death mechanisms 
which are monitored by ER stress signaling. 
1.4.1. Apoptosis 
The word ‘apoptosis’ was introduced first time by Kerr, Wyllie, and Currie in 1972, to 
identify a distinct and conserved model of cell death which possesses different morphological 
changings 72. Significant morphologies of apoptosis are membrane blebbing, cell shrinkage, 
nuclear fragmentation and chromatin condensation 73. 
Apoptosis is also known as programmed cell death (type-I programmed cell death) so that its 
regulation is genetically monitored. The genes that contributing to programmed death of cells 
was firstly identified in the nematode Caenorhabditis elegans. During its developmental 
process, the number of cells in the nematode reduces to 959 from total of 1090 cells. This 
organized clearance of 131 cell is conducted by apoptosis. Brenner, Horvitz and Sulston 
identified the C. elegans death (ced) genes and they showed the significant role of ced-3 and 
ced-4 genes in cell death 74. 
Human homologs of ced are the cysteine proteases ‘caspases’ that cleave their targets by 
proteolytic activity after only aspartate residues. First introduced mammalian caspase protein 
was ICE (interleukin-1L converting enzyme) called now caspase-1. Caspases have central 
roles in apoptosis pathway are caspase-2, -3, -6, -7, -8, -9 and -10. Other caspases such as 
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caspase-1, -4 and -5 participate in inflammation. Caspases are inactive zymogens and they 
are activated upon apoptotic stimuli 75. 
Physiological cell death during development of multicellular organisms is conducted by 
apoptosis to support tissue and organ homeostasis. Precisely regulated machinery of 
apoptosis eliminates the web structure between digits in fingers and toes in human embryonic 
stage. Role of apoptosis in development and growth can be exemplified as forming vertebrate 
central nervous system and palate, and controlling amphibian metamorphosis 76. Removal of 
damaged, infected, malfunctioning, unhealthy or unnecessary cells by apoptosis is 
advantageous and favorable for organisms in terms of preventing diseases that resulting from 
malfunctioning of cells. 
Molecular mechanism of apoptosis relies on two main pathways: extrinsic and intrinsic 
pathway (Figure 1.3). Extrinsic pathway, also known as death receptor pathway is activated 
via death receptors on the cell surface. Death ligands TNFα (tumor necrosis factor α), TRAIL 
(TNF-related apoptosis-inducing ligand) and FasL bind their corresponded receptors TNFR, 
TRAIL-R1/DR4, TRAIL-R2/DR5 and FasR, and trigger their oligomerization. Adaptor 
protein FADD (Fas-associated death domain) containing death domain then recruit initiator 
inactive caspases, pro-caspase-8 and pro-caspase-10, and form DISC (death-inducing 
signaling complex) to convey downstream death signaling. Once DISC is assembled, initiator 
caspases (pro-caspase-8 and pro-caspase-10) are cleaved and become active via 
autocatalysis. Other adaptor protein TRADD (TNF receptor-associated death domain) 
recruits FADD and pro-caspase-8 upon TNFR stimulation. FADD and TRADD interact via 
their death domains and form a complex to activate pro-caspase-8. Activated caspase-8 
directly cleave and activate effector caspases caspase-3, caspase-6 and caspase-7. Active 
effector caspases execute apoptotic death of cell. Inhibition of cell surface receptor-mediated 
death pathway can be processed by c-FLIP (Cellular FLICE (FADD-like IL-1β-converting 
enzyme)-inhibitory protein) which targets and binds to DISC through FADD to make it 
unable to initiate and transmit apoptotic cascade 73, 77. 
Second pathway of apoptosis is intrinsic or mitochondria-dependent pathway. Initiation of 
intrinsic pathway is triggered by various intracellular stimuli such as hypoxia, DNA damage, 
growth factor deprivation,  accumulation of misfolded proteins,  heat shock,  osmotic shock,  
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Figure 1.3. Extrinsic and intrinsic pathways of apoptotic death signaling. Cell surface 
death receptor activation by death ligands initiates extrinsic pathway of apoptosis. Death 
domain containing adaptor proteins and inactive pro-caspases are then recruited to form 
DISC. Following their cleavage, active initiator caspases target effector caspases to execute 
apoptosis. In intrinsic pathway, intracellular stimuli trigger the expression of pro-apoptotic 
BH3-only proteins that activates Bak/Bax proteins to initiate death signaling. Activated Bak 
and Bax cause MOMP, and cytochrome c release mediates downstream caspase activation, 
eventually apoptotic cell death. Anti-apoptotic Bcl-2 family proteins involve in the regulation 
of intrinsic pathway of apoptosis 77. 
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UV radiation, oxidative stress, calcium imbalance and drugs. Maintenance of mitochondrial 
integrity is supervised by pro-apoptotic and anti-apoptotic members of Bcl-2 family proteins. 
Intracellular stimuli cause oligomerization of pro-apoptotic Bcl-2 proteins Bax and Bak on 
the outer membrane of mitochondria and this oligomerization leads pore formation on the 
outer membrane, stated as mitochondrial outer membrane permeabilization (MOMP). 
MOMP allows leaking of proteins from intermembrane space of mitochondria into the 
cytosol 78. One of these proteins is cytochrome c which binds to Apaf-1 (Apoptotic protease 
activating factor-1) to build ‘apoptosome’ complex. Apoptosome  recruits  pro-caspase-9  
and  activates  it  to  initiate  downstream  cascade. Cleaved caspase-9 then activates effector 
caspases caspase-3, caspase-6 and caspase-7 to complete cell demise process. Other proteins 
that are released via MOMP action are Smac/DIABLO (second mitochondria-derived 
activator of caspase/direct IAP-binding protein with low pl), HtrA serine protease 2/Omi, 
AIF (apoptosis-inducing factor) and endonuclease G 78. These released proteins are also 
involved in the regulation of apoptosis signaling. Smac/DIABLO and HtrA2/Omi bind IAP 
(inhibitors of apoptosis) proteins and prevent IAPs’ inhibitory action on caspase-3, -7 and -
9. AIF and endonuclease G participate in apoptosis initiation through a caspase-independent 
pathway. They are responsible for DNA fragmentation which is considered as an intracellular 
stimulus of cell death 73.  
Connection between the extrinsic and intrinsic pathway of apoptosis is carried out by the Bcl-
2 family protein Bid (BH3-interacting DD agonist). The route of transition is occurring from 
extrinsic death pathway to intrinsic mitochondrial pathway. Bid is firstly cleaved by caspase-
8. Cleaved Bid is called truncated-Bid (tBid). Then, tBid is translocated to the mitochondria 
to interact with Bcl-2 members. As a consequence, tBid generates a mitochondria-dependent 
cell execution by a death receptor-mediated signaling 79. 
After cells are killed by apoptosis machinery, apoptotic body structures that composed of 
cellular remaining take place. This apoptotic bodies are engulfed by phagocytic cells that are 
able to recognize “eat me” signals of dying cells. Facilitated clean-up does not cause any 
inflammation since spills of dying cell are enclosed by apoptotic bodies 73. 
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1.4.2. Bcl-2 Family Proteins and Their Role in ER Stress 
The members of Bcl-2 family proteins are major controllers of apoptotic cell death. They 
mainly administer the balance between cell death and cell survival mechanisms through their 
pro-apoptotic and anti-apoptotic characteristics. Bcl-2 family proteins can be separated into 
three sub-class according to their apoptotic features and domains they contain in their protein 
structure: anti-apoptotic Bcl-2 proteins, pro-apoptotic multi-domain Bcl-2 proteins and pro-
apoptotic BH3 only proteins. 
Anti-apoptotic Bcl-2 proteins are Bcl-2, Bcl-xL (B-cell lymphoma extra-large, or Bcl-2-like 
protein 1), Bcl-w (Bcl-2-like protein 2), Mcl-1 (myeloid cell leukemia 1), A1/BFL-1 (BCL2 
related protein A1), Boo/Diva/Bcl-B (Bcl-2-like protein 10) and NR-13. They are multi-
domain proteins that contain Bcl-2 homology (BH) domains BH1, BH2, BH3 and BH4. 
Additionally, they also have a transmembrane domain (TM). They are generally located on 
the outer membrane of mitochondria, ER membrane or cytosol, however they translocate to 
MOM and ER by depending on activation 80. Since this group of Bcl-2 family is known as 
anti-apoptotic or pro-survival, they are able to prevent the formation of MOMP by interacting 
pro-apoptotic members of Bcl-2 protein family 81. 
Pro-apoptotic members of multi-domain Bcl-2 proteins are Bak (Bcl-2 homologous 
antagonist killer), Bax (Bcl-2 associated X protein) and Bok (Bcl-2 related ovarian killer). 
They have BH1, BH2 and BH3 domains in their structure. In the absence of apoptotic stimuli, 
subcellular location of Bax is the cytosol. Upon activation, Bax is translocated to 
mitochondria, and together with Bak, undergoes a conformational change. Bak and Bax then 
oligomerize on mitochondrial outer membrane and create pores on the membrane, resulting 
to permeabilization in the end 80. 
Other group of pro-apoptotic proteins contains only BH3 domain so called BH3-only 
proteins. This group includes Bid (BH3-interacting domain death agonist), Bad (Bcl-2-
associated death promoter) Bim (Bcl-2 interacting mediator of cell death), Bik (Bcl-2 
Interacting Killer), Bmf (Bcl2 Modifying Factor), Hrk (Harakiri), Noxa and Puma 82. 
Interaction of pro-apoptotic and anti-apoptotic proteins is mediated via shared BH3 domain, 
the only common domain in all Bcl-2 family proteins. The best-known interaction occurs 
between anti-apoptotic Bcl-2-like proteins and pro-apoptotic Bak/Bax 80. Interaction through 
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BH3 domain is not restricted to only between anti-apoptotic and pro-apoptotic members of 
the family. Single-domain pro-apoptotic proteins also can bind Bak and Bax, multi-domain 
pro-apoptotic proteins. Bak and Bak can be activated by directly binding of BH3-only 
proteins Bim, tBid and Puma. At the same time, all BH3-only proteins can cause indirect 
activation of Bak/Bax by interacting anti-apoptotic members of Bcl-2 protein family 83.   
Sensitizers Bad, Bmf, Bik, Hrk, Puma and Noxa selectively interact and sequester anti-
apoptotic Bcl-2 proteins to prevent their pro-survival actions. For instance, Noxa is highly 
specific to Mcl-1 and Bad targets Bcl-2, Bcl-w and Bcl-xL. Bik and Bmf antagonize to all 
anti-apoptotic Bcl-2 proteins while Hrk is attracted only by Bcl-xL 81, 82.  
Bax and Bak are Bcl-2 family proteins that localize on ER membrane. It is reported that they 
may have a role at ER stress-induced cell death since bak-/- and bax-/- double knock-out 
mice show resistance to ER stress-mediated apoptosis 84. Regulation of ER calcium 
homeostasis by Bak and Bax shows the importance of these proteins for ER 85. Anti-apoptotic 
members of Bcl-2 family tend to decrease the level of free ER calcium however Bak and Bax 
increase the calcium concentration 86. 
Similar to Bak and Bax, puma-/- and noxa-/- cells are found to be resistant to apoptotic cell 
death monitored by ER stress. Puma and Noxa are indicated as highly expressed during ER 
stress-induced apoptosis 87. Increase in the expression of Puma was found to be related to 
reduction of ER Ca+2 levels by Bax protein 88. 
ER stress-induced apoptosis is triggered through the increased expression of BH3-only 
protein Bim which is controlled transcriptionally by CHOP 89.  
Bcl-2 and Bcl-xL also can be positioned on the ER membrane and they show protective 
behaviors against ER stress 15. 
It is also reported that Bcl-2 family proteins can directly affect the regulation of IRE1 90. 
1.4.3. Apoptotic Cell Death Regulation by UPR elements 
Excessive ER stress leads to the initiation of signaling pathways that triggering apoptotic cell 
death. Three UPR sensor proteins that are mainly programmed to maintain survival of cell 
can also induce the activation of cell death mechanisms. Almost all components of UPR 
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signaling involve in the different levels of ER stress-induced apoptotic cell death pathway 
(Figure 1.4). 
ATF6 is generally known as adaptive pro-survival 53, 55. However, the selection of target in 
order to activate is dependent on the stimulus and cell type, the downstream target of ATF6 
signaling can be either pro-survival or pro-death gene 10. 
In the PERK-dependent branch of UPR, ATF4 is responsible from the synthesis of genes 
related to protein synthesis, secretion and transport. CHOP is a well-known target of 
transcription factor ATF4 in PERK signaling cascade. Following the induction, CHOP is able 
to prevent ATF4 synthesis and its own synthesis. This is an example of how 
PERK/ATF4/CHOP pathway contributes to cell death 86. In one study, the level of anti-
apoptotic Mcl-1 was reduced through an ATF4-dependent signaling 91. CHOP can activate 
the expression of genes that controlling cell death such as DR5 (death receptor 5), also known 
as TRAIL-R2, in a caspase-8 dependent manner 92. In chop-/- mice, decreased rate of 
apoptosis is observed in response to ER stress 19. On the other hand, overexpressed CHOP 
causes a reduction in protein level of anti-apoptotic Bcl-2, and Bcl-2 overexpression prevents 
CHOP-mediated apoptotic cell death 21.  
Decision of cell fate, either death or survival, by IRE1α is affected by the duration and 
severeness of ER stress. IRE1α promotes apoptotic cell death through activating ASK1 
(apoptosis signal-regulating kinase 1) and its target JNK (c-Jun N- terminal kinase 1) by the 
adaptor protein TRAF2 (TNF receptor-associated factor 2). Pro-apoptotic JNK induces the 
activation of pro-apoptotic Bim while it inhibits anti-apoptotic Bcl-2 protein 86. RIDD, the 
mRNA decay mechanism mediated by IRE1, helps alleviation of proteins in the ER to keep 
homeostasis in steady state. However, excess and constant RIDD processing can activates 
the expression of pro-death genes 26. The transcription factor XBP1 play a significant role in 
cell survival 86. Inactivation of XBP1 is associated with increasing rate of apoptosis in cancer 
cells 15. Coherently, Bcl-2 protein levels was increased by depending on the overexpression 
of XBP1 in MCF7 cells 93. 
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Figure 1.4. ER stress-induced cell death. Three UPR sensor proteins involve in apoptosis 
machinery. After its cleavage, ATF6 can activate transcription factor CHOP. PERK also 
induces CHOP through the phosphorylation of eIF2α, and ATF4 targets Noxa to activate Bak 
and Bax. CHOP induces Bim and inhibits Bcl-2 family members. Stimulated IRE1 recruits 
the adaptor protein TRAF2 which activates ASK1 and its downstream element JNK. JNK is 
able to initiate apoptosis signaling by inactivating anti-apoptotic proteins of Bcl-2 family 86. 
1.4.4. Calcium Crosstalk Between ER and Mitochondria 
ER is the primary storage place of calcium. To function normally, ER requires higher level 
of free calcium ion (500-1000μM) in ER lumen. Hence, a reduction in the level of Ca+2 ions 
can promote the activation of death signaling pathways since keeping Ca+2 levels stable in 
ER is vital for the ER homeostasis. Many chaperones of the ER work actively and efficiently 
with the existence of Ca+2 ions. Uptake of Ca+2 into ER is achieved by SERCA pumps, and 
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release of Ca+2 ions is processed through the inositol trisphosphate receptor (IP3R) calcium 
channels or ryanodine receptors 94. Maintenance of ER calcium homeostasis is regulated by 
Bcl-2 family members. Studies show that Bcl-2 and Bcl-xL control ER calcium concentration 
by monitoring IP3R channel opening and play protective role against apoptosis 94, 95. Another 
study reported that IP3R channels are also controlled by CHOP-regulated ERO1α 
(Endoplasmic Reticulum Oxidoreductase 1α) expression 96. ERO1α induces calcium release 
from IP3R channels of ER during ER stress and triggers cell death. 
Released free Ca+2 from ER is important for the homeostasis of mitochondria since Ca+2 can 
be up-taken by mitochondria. This calcium transfer procedure is mediated by the contact 
regions called mitochondria associated ER membranes (MAMs), where mitochondria and 
ER are in a very close-range via tethering. In MAM sites, released Ca+2 is accumulated in 
microdomains, and here take-up process is followed easily. Voltage-dependent anion channel 
(VDAC) play a crucial role in the sequestering of Ca+2 ions. Mitochondrial Ca+2 uniporters 
(MCUs) also involve in this process 97. 
Calcium crosstalk between ER and mitochondria can also be ruled by Akt/PKB (Protein 
kinase B) 98. Akt is able to phosphorylate IP3R channels and prevents the leakage of  Ca+2 
ions, ultimately apoptosis 99. 
Prolonged ER stress causes the continuous release of calcium ions from ER lumen. Higher 
concentration of calcium that is taken by microdomains of mitochondria may drive apoptosis 
induced by the overload of calcium 88. 
1.5. Calcium-Activated Nucleotidase 1 (CANT1) 
Calcium-activated nucleotidase 1 (CANT1) belongs to apyrases family of enzymes that are 
responsible for hydrolysis of extracellular adenosine triphosphate and diphosphate (ATP, 
ADP) to adenosine monophosphate (AMP). 
Apyrases (ATP-diphosphatase, ATP di-phosphohydrolase, adenosine diphosphatase, 
ADPase) family was firstly introduced as salivary apyrases in the blood-feeding arthropods. 
Human homologue of apyrase from arthropod bed bug Cimex lectularius was identified by 
Smith and Kirley in 2002. It was found that the enzymatic activation of the new nucleotidase 
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depends on calcium ion, therefore it is named human soluble calcium-activated nucleotidase 
1 (hSCAN-1). Cloning, expression and characterization of SCAN-1 was performed in the 
same study 100.  
Although apyrases are defined as ATP and ADP hydrolyzing enzymes, the preferential order 
of SCAN-1 substrates are indicated as UDP, GDP, UTP, GTP, ADP and ATP, respectively 
100. Addition to that, hSCAN-1 is not able to digest nucleoside monophosphates.  
Bacterial expression of hSCAN-1 was performed and fully functional enzyme was obtained 
101. Refolding and constructing hSCAN-1 in bacteria did not affect enzymatic activity and 
this study showed that post-translational modifications are not required for the nucleotidase 
to function properly, since bacterial expression system does not process the post-translational 
modifications. In order to identify essential residues for the nucleotidase activity and 
enzymatic specificity of hSCAN-1, mutations were generated by site-directed mutagenesis 
method 102.  
hSCAN-1/CANT1 is encoded by human CANT1 gene situating at the q arm of chromosome 
17. Protein product of this gene has a molecular mass of 34-37 kDa according to western blot 
and size-exclusion chromatography 100. Secreted form of the enzyme exists, and the 
subcellular distribution of rat homologue of CANT1 was displayed on ER and ER-Golgi 
transition sites, since RXR ER retention motif leads to holding the Ca+2 nucleotidase on the 
ER 103.  
Multiple tissue expression analysis revealed the highest mRNA levels in prostate, small 
intestine, testis and placenta. Lower level of mRNA was found in lung, stomach, spleen and 
thymus 100. 
Mutation in CANT1 gene causes Desbuquois dysplasia which is an autosomal recessive 
disorder causing growth retardation includes skeletal disfunctions such as joint dislocations, 
hand and femur abnormalities 104, 105. In addition to the type I and type II variants of the 
disease, Kim variant of Desbuquois dysplasia was also defined with the additional hand bone 
abnormalities 106. The role of CANT1 mutation in this disorder is unclear however one study 
suggests that CANT1 in Desbuquois dysplasia might involve in proteoglycan metabolism 107. 
It is also speculated that the detected accumulation of inclusion bodies in ER in Desbuquois 
dysplasia patients might be associated with improper protein folding and accumulation of 
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misfolded proteins 105. Furthermore, one recent study showed that mutations in CANT1 also 
cause multiple epiphyseal dysplasia (MED) which possesses clinically different 
characteristics from all defined types of Desbuquois dysplasia 108. 
Hermans et al. reported that the expression of CANT1 is regulated by androgen in prostate 
cancer 109. Androgen-regulated CANT1 expression pattern was also elaborated in different 
phases of prostate carcinogenesis in a comprehensive manner 110. 
One study identifying CANT1 as a target of calcium-dependent transcriptional repressor 
DREAM (Downstream regulatory element antagonist modulator) proposes that CANT1 may 
have a role in protein synthesis and degradation, since CANT1 downregulation is associated 
with increasing rate of protein degradation 111.  
Additionally, APY-1, the Caenorhabditis elegans homologue of CANT1, involves in UPR 
signaling in the nematode since the expression of apy-1 is up-regulated upon ER stress 
signaling 112.
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2. AIM OF THE STUDY 
In the literature, ER-related roles and functions have been suggested for CANT1 since 
CANT1 is an ER-resident protein. CANT1 expression was studied in prostate cancer cells 
previously, regarding its high level of expression in prostate tissue. However, we did not 
come across any study showing the regulation of CANT1 expression in breast cancer cells. 
Thus, in this study, we aimed to identify how CANT1 expression is regulated in breast cancer 
cell lines through ER stress-induced cell death. Thapsigargin was given to MCF7, SK-BR-3 
and MDA-MB-468 cells to generate ER stress by disrupting calcium homeostasis. Following 
that, we hypothesized the expression of calcium-activated protein CANT1 is effected in terms 
of protein and mRNA level when ER becomes Ca+2 deficient. We also wanted to learn if ER 
stress has an impact on alteration of the localization of ER-resident protein CANT1, or not. 
With other words, we thought that CANT1 localization can be affected in the lack of calcium 
in ER since Ca+2 is the cofactor for CANT1 activation. Therefore, we focused on the 
colocalization of CANT1 with ER and mitochondria by considering calcium crosstalk 
between ER and mitochondria. 
By depending on our knowledge so far, this study is the first research which investigates the 
regulation of CANT1 expression in breast cancer cells that undergoing ER stress-induced 
cell death.
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3. MATERIALS & METHODS 
3.1. Materials 
3.1.1. Chemicals 
All chemicals used in this thesis are listed in Appendix A. 
3.1.2. Equipment 
Equipment used in this thesis are listed in Appendix B. 
3.1.3. Solutions and Buffers 
All solutions and buffers used in this study are listed in Appendix C. 
3.1.4. Growth Media 
DMEM/F12 (1:1): DMEM/F12 growth medium was supplemented with 10% fetal bovine 
serum (FBS) and 1% Pen/Strep (100 Units/ml Penicillin and 100 μg/ml Streptomycin) 
antibiotics. 
Freezing Medium: Freezing medium containing 20% DMSO and 80% FBS was used to 
freeze all mammalian cell lines. 
3.1.5. Molecular Biology Kits and Reagents 
Molecular biology kits and reagents that are used in experiments in this thesis are listed in 
Appendix D. 
3.1.6. Antibodies 
Antibodies used in this thesis are listed in Appendix E. 
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3.1.7. Mammalian Cell Lines 
ATCC Breast Cancer Cell Panel (30-4500K™) (Appendix F) and PC3 cells (ATCC® CRL-
1435™) were used to screen the expression level of CANT1 protein endogenously. MCF7 
(ATCC® HTB-22™), SK-BR-3 ([SKBR3] ATCC® HTB-30™) and MDA-MB-468 
(ATCC® HTB-132™) breast cancer cell lines were used in the other experiments conducted 
in this thesis.  
3.1.8. Protein Molecular Weight Marker 
Protein molecular weight marker used in this thesis is listed in Appendix G. 
3.1.9. Software and Programs 
All software and computer-based programs that are used in this thesis are given in Table 3.1. 
SOFTWARE, 
PROGRAM NAME 
COMPANY PURPOSE OF USE 
CoLocalizer Pro 3.0.2 CoLocalization Research 
Software 
Colocalization analysis of 
confocal images 
GraphPad Prism 5 
 
GraphPad Software Design of graphics 
ImageJ 1.51w 
 
National Institutes of 
Health (NIH) 
Densiometric analysis of 
immunoblot results 
ZEN Blue edition 2.3 
 
Carl Zeiss Microscopy Post-processing of 
confocal images 
RStudio Version 1.1.442 
 
 RStudio, Inc. Statistical data analysis 
 
Table 3.1. List of software and computer-based programs. 
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3.2. Methods 
3.2.1. Mammalian Cell Culture 
3.2.1.1. Maintenance of cell lines 
MCF7, SK-BR-3 and MDA-MB-468 cells were grown in DMEM/F12 (1:1) complete 
medium and cells were incubated at 37°C with 5% CO2. The subculturing of cells was done 
when they reached their confluency. Subculturing process was performed by washing the 
cells with 1X sterile PBS and detaching cells with proper amount of Trypsin-EDTA. By 
depending on experimental purpose, cells were seeded in new sterile 6-well, 12-well, 96-well 
or 100 mm cell culture plates. 
3.2.1.2. Cryopreservation of the cells  
Mammalian cells were frozen with freezing medium and kept in liquid nitrogen for further 
use. Cells were washed with 1X sterile PBS and trypsinized for harvesting. After cell 
counting, 3-5x106 cells were centrifuged at 300 g for 5 minutes. Then, cell pellet was 
resuspended with 1 ml freezing medium containing FBS and DMSO and transferred into 
cryovial. Cryovials were kept in a freezing container and the container was stored in a -80°C 
freezer to allow the temperature decrease gradually. Next day, cryovials were transferred into 
liquid nitrogen for long term storage. 
3.2.1.3. Thawing frozen mammalian cells 
Quick-thaw method was followed to thaw the cells from liquid nitrogen store. Cells were 
thawed in a 37°C water bath and immediately transferred into 15 ml centrifuge tube 
containing 9 ml of growth medium. For the removal of DMSO, centrifugation was done at 
300 g for 5 minutes. Cell pellet was resuspended with growth medium and transferred into 
sterile cell culture plate and incubated at 37°C with 5% CO2.  
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3.2.2. Treatments 
Thapsigargin (THG, MW: 650.76 g/mol) was dissolved in DMSO and kept in -20°C. Dose-
dependent (10nM, 100nM and 1μM) or time-dependent (4h, 8h, 16h, 24h and 48h) THG 
treatments were performed on MCF7, SK-BR-3 and MDA-MB-468 cells. 
3.2.3. Cell Viability Assay 
To detect the viabilities of cells that were exposed to THG, Cell Proliferation Reagent WST-
1 Assay (Roche) manufacturer’s protocol was followed. Briefly, MCF7, SK-BR-3 and MDA-
MB-468 cells were seeded into 96-well plate and treated with THG as time- and dose-
dependent. Then, 10 μl WST-1 reagent per well was added to cells and cells were incubated 
at 37°C for 4 hours. Absorbance was measured at 450nm wavelength by a microplate reader. 
Obtained absorbance results were demonstrated as percentage of cell viability. The 
absorbance of control condition was set to 100%. 
3.2.4. Western Blotting 
3.2.4.1. Cell harvest, cell lysis and protein isolation 
Growth medium was aspirated, and cells were washed with 1X PBS. Then 1 ml of 1X PBS 
added to plate, and cells were collected by cell scraper and transferred into 1.5 ml centrifuge 
tube. Cells were span down at 300 g for 5 minutes and supernatant was removed. Cell pellet 
was dissolved with 1% Chaps buffer containing 5mM MgCl2, 137mM KCl, 1mM EDTA, 
1mM EGTA, 20mM Tris-HCl and 1% Chaps. Resuspended cells was incubated on ice for 
30 minutes. Then, the lysate was centrifuged at 4°C and 13200 rpm for 10 minutes. Isolated 
proteins were stored at -20°C. 
3.2.4.2. Measurement of protein concentration 
Quick Start Bradford Assay was followed to measure the total protein concentration after 
isolation. Briefly, protein samples were diluted as 1:5 with double-distilled water and added 
into 96-well plate, and then 250 μl of Bradford solution was added per well. After 10 minutes 
incubation in dark, plate was read at 595nm wavelength in a microplate reader. M
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absorbance results were used to determine protein concentrations with protein standard curve 
that was generated from absorbance measurement of BSA protein standards. 
3.2.4.3. Preparation of SDS gel 
12% SDS gel was prepared as indicated amounts in Table 3.2. 
12% SDS PAGE Gel for 1 gel (5 ml) 
Acrylamide/Bis (30%) 2 ml 
ddH2O 1.75 ml 
Tris-HCl-SDS, pH:8.8 1.25 ml 
APS 17 μl 
TEMED 3.5 μl 
 
Table 3.2. Solutions for preparing 12% separating gel. 
Spacer plate and short plate were placed in casting frame. Separating gel was poured between 
glass plates and isopropanol was added on top. After the gel was completely polymerized, 
isopropanol was removed, and gel was washed with ddH2O several times. Then, stacking gel 
(Table 3.3) was poured and comb was placed. 
Stacking Gel for 1 gel 
Acrylamide/Bis (30%) 325 μl 
ddH2O 1525 μl 
Tris-HCl-SDS, pH:6.8 625 μl 
APS 12.5 μl 
TEMED 2.5 μl 
 
Table 3.3. Solutions for stacking gel. 
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3.2.4.4. Sample preparation for loading 
According to measured concentrations and determined loading amounts (μg), protein 
samples were mixed with appropriate volumes of loading buffer (4% SDS, 20% glycerol, 
10% 2-mercaptoethanol, 0.004% bromophenol blue, 0.125 M Tris/HCl pH:6.8). Then, they 
were boiled at 95°C for 5 minutes and shortly span down before loading to gel. 
3.2.4.5. Running SDS-PAGE 
After gel cassette system was assembled for run, prepared samples were loaded into the gel. 
1X running buffer was poured between the gel cassette system and into tank. SDS-PAGE 
was run at a constant voltage 100V. 
3.2.4.6. Blotting (Wet transfer) 
Proteins were blotted onto the membrane after the run was completed. Basically, two transfer 
sponges and two filter papers were submerged in freshly prepared 1X Transfer buffer. 
Polyvinylidene difluoride (PVDF) membrane was activated with 100% methanol and the 
transfer system was assembled. The closed cassette and ice block were then placed in the 
transfer tank and the tank was filled with 1X Transfer buffer. Blotting conditions was set as 
100V, 260mA and 60 minutes. 
3.2.4.7. Membrane blocking and antibody incubations 
Blocking of the membrane was done with 5% milk in PBS-T solution, at the room 
temperature on a shaker for 1 hour. Then, primary antibody incubation was carried out as 
adding diluted antibody (1 μg/μl) into primary antibody incubation solution. Incubation was 
proceeded overnight at 4°C. After primary antibody incubation, membrane was washed with 
PBS-T solution for 10 minutes. This wash step was repeated for three times. HRP-linked 
secondary antibody was prepared in 5% milk solution and incubation was done in the room 
temperature for 1 hour.  
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3.2.4.8. ECL incubation and imaging 
After required washes with PBS-T solution, the membrane was incubated with commercial 
ECL (Luminata Crescendo Western HRP Substrate, Millipore, USA) for 1 minute and bands 
were visualized by LAS4000 imaging system (Fujifilm, Japan). 
3.2.4.9. Densiometric analysis 
Densiometric analysis of western blotting results was performed in ImageJ software by 
normalizing CANT1 protein band densities to corresponded Actin band densities. Analysis 
results were expressed as percentages.  
3.2.5. RNA Isolation 
Cells were washed with sterile 1X PBS and were detached by trypsinization. Collected cells 
were centrifuged at 300 g for 5 minutes. Then, total RNA was isolated by RNeasy RNA 
isolation kit (Qiagen, Germany) according to manufacturer’s protocol. Total RNA 
concentrations and A260/A280 ratio were measured and determined spectrophotometrically by 
NanoDrop 2000 (Thermo Fisher). 
3.2.6. Real time RT-PCR 
Quantification of RNA was conducted by real-time one-step RT-PCR SYBR Green I 
detection. QuantiTect SYBR Green RT-PCR Kit (Qiagen, Germany) was used to quantify 
CANT1 gene expression. Experimental setup was followed according to manufacturer’s 
protocol. Briefly, master mixes were prepared for CANT1 and GAPDH primers (Table 3.4) 
that were purchased as QuantiTect Primer Assays (Qiagen) and 200 ng template RNA were 
used per reaction (Table 3.5).  
PRIMER NAME CATALOG NUMBER COMPANY 
CANT1 QT00003444 QIAGEN 
GAPDH QT00079247 QIAGEN 
 
Table 3.4. Primers used in real-time one-step RT-PCR analysis. 
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Component Volume/reaction Final Concentration 
2X SYBR Green Master 
mix 
5 μl 1X 
10X Primer  1 μl 1X 
RT Mix 0.1 μl - 
Template RNA Variable 200 ng/μl 
RNase-free water Variable - 
Total reaction volume              10 μl 
 
Table 3.5. Reaction setup for real-time one-step RT-PCR.  
 
After reaction mixture was prepared, PCR was run at LightCycler 480 (Roche, Germany) 
with the cycling conditions indicated in Table 3.6. 
 
Reverse transcription reaction 50°C 30 minutes 
Pre-incubation 95°C 15 minutes 
Amplification  
(40 cycles) 
Denaturation 94°C 15 seconds 
Annealing 55°C 30 seconds 
Extension 72°C 30 seconds 
Cooling 40°C 30 seconds 
 
Table 3.6. PCR cycling conditions. 
 
Data acquisition was performed at the end of each extension step. Obtained CT values of 
target gene were normalized to expression of the housekeeping gene GAPDH and the fold 
change was relatively quantified by 2-ΔΔCT method 113.  
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3.2.7. Immunofluorescence  
3.2.7.1. Staining of subcellular structures 
Breast cancer cells (3x104 cells/well) were seeded on sterile coverslips (Jena Biosciences 
circular cover slide 0.22mm, CSL104) that were placed in 12-well plate. After cells were 
attached on the coverslips, mitochondria and endoplasmic reticulum were stained with Mito-
Tracker Red and ER-Tracker Red dyes, respectively. The final concentration of Mito-Tracker 
Red was determined as 100nM and the concentration was 500nM for ER-Tracker Red. The 
dyes were given to cells and cells were incubated in 37°C. Incubation times of dyes were set 
as 5 minutes for Mito-Tracker Red and 15 minutes for ER-Tracker Red. 
3.2.7.2. Fixation and permeabilization 
After organelle staining, cells were washed with 1X PBS for 10 minutes. Washing was 
repeated three times. Then, cells were fixed with 4% PFA (paraformaldehyde) solution for 
10 minutes and washing steps were followed. For permeabilization of cell membrane, 0.5% 
Triton X-100 was given and incubated for 5 minutes. Then, cells were washed again as it is 
described before. 
3.2.7.3. Blocking, antibody incubations and mounting 
Before antibody incubation, cells were blocked with 0.1% Blocking solution on a shaker for 
30 minutes. Then, primary antibody CANT1 was prepared as 1 μg/μl in blocking solution 
and incubated overnight at 4°C. After 16 hours, 10 minutes wash with 1X PBS was repeated 
three times. Secondary antibody Alexa Fluor® 488 was prepared and incubated at dark for 1 
hour. After washing of secondary antibody, DAPI staining of cell nuclei was carried out on 
a shaker for 10 minutes and required washes were followed. Cells were mounted with 
mounting solution on the microscope slides, and coverslip was sealed with transparent nail 
polish. 
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3.2.7.4. Confocal imaging 
Immunostained cells were visualized by Zeiss LSM 710 Confocal Microscope. Observation 
and image capture was done through 63x oil immersion objective. Lasers used to excite 
fluorophores and excitation-emission maxima of fluorophores used in imaging are given in 
Table 3.7. 
Stain/Channel Excitation maxima Emission maxima Laser 
DAPI 405nm 459nm UV Laser 
Alexa Fluor® 488 488nm 530nm Argon Laser 
ER-Tracker Red 587nm 615nm DPSS 561-10 Laser 
Mito-Tracker Red 560nm 630nm DPSS 561-10 Laser 
 
Table 3.7. Fluorophores, their excitation-emission maxima, and the lasers used to excite 
these fluorophores. 
3.2.7.5. Post-processing and colocalization analysis 
Captured images were saved as .lsm file. Post-processing was conducted in ZEN software 
(Blue edition 2.3). Images in .lsm format were split into three channels and then converted 
into .tiff format in ZEN Blue software. Confocal images in .tiff format were analyzed by 
CoLocalizer Pro (3.0.2) software in order to quantify colocalization. In colocalization 
analysis, signal intensity of pixels in channels was detected, and Pearson’s coefficient (Rr) 
and Manders’ overlap coefficient (R) were calculated to evaluate colocalization of two 
channels (red-green) 114.  
3.2.8. Statistical Analysis 
Quantified results are expressed as mean ± SEM values. Statistical significance of the results 
was analyzed by the Student's t-tail test, and *P<0.05, **P<0.01 and ***P<0.001 were 
considered statistically significant.
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4. RESULTS 
4.1. CANT1 Protein Expression Screening of Breast Cancer Cell Line Panel 
Total of forty breast cancer cell lines, four normal breast epithelial cell lines from ATCC 
breast cancer cell line panel (Appendix F) were screened to detect CANT1 protein expression 
level endogenously. Prostate cancer cell line PC3 was also involved in this screening because 
it was previously reported that CANT1 is one of the upregulated genes in prostate cancer 100, 
110. Proteins are collected from total forty-five cell lines, as it was described in the Methods 
section. 30 μg of total protein loaded and run for each cell line. Protein expressions were 
analyzed by western blot (Figure 4.1). Anti-CANT1 monoclonal antibody (C-3, sc-515574, 
Santa Cruz Biotechnology) was used for immunodetection of CANT1 protein. Obtained 
CANT1 bands possessed different expression patterns, and CANT1 signals varied with a 
range of 40-45 kDa among cell lines.  
According to the results of screening, we decided to continue our studies with MCF7, SK-
BR-3 and MDA-MB-468 cells. SK-BR-3 was one of the cell lines that express CANT1 
protein highly in western blot results. We then chose MCF7 and MDA-MB-468 cells that 
have relatively less CANT1 protein levels. Additionally, to consider their receptor status, 
HER2 (human epidermal growth factor receptor 2) is overexpressed in SK-BR-3. On the 
other hand, SK-BR-3 is estrogen receptor negative (ER-) but MCF7 is an estrogen receptor-
positive (ER+) cell line. MCF7 also has a highly active progesterone receptor (PR) gene. 
More, MDA-MB-468 is reported as a triple negative cell line that does not express ER, HER2 
and PR 115, 116, 117. As a result, we have representatives from three different groups of breast 
cancer cell lines classification for our further experiments: HER2+, ER-, PR- (SK-BR-3), 
HER2-, ER+, PR+ (MCF7) and HER2-, ER-, PR- (MDA-MB-468). 
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Figure 4.1. Screening the expression of CANT1 in protein level. Forty breast cancer cell 
lines, four normal breast epithelial cells (184B5, MCF-10A, MCF-10F, MCF-12A) from 
ATCC breast cancer cell panel and prostate cancer cell line PC3 were screened to detect 
endogenous CANT1 protein levels. 30 μg total protein extract loaded into 12% gel for each 
cell line and protein expression levels were analyzed by immunoblotting. Molecular weight 
of detected CANT1 signals varies between 40-45 kDa. 
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4.2. Effect of Thapsigargin Concentration and Exposure Time on Cell Death in 
Breast Cancer Cell Lines 
Selected three cell lines, MCF7, SK-BR-3, MDA-MB-468, were treated with THG in dose- 
or time-dependent manner. Effect of THG on cell viability of three different cell lines was 
determined by WST-1 Cell Proliferation Assay (Roche). Mean values of obtained viability 
results are expressed as percentage in Figure 4.2 for dose-dependent and in Figure 4.3 for 
time-dependent treatments. In the dose-dependent case, even the lowest concentration 
(10nM) of THG caused a sharp reduction in the viabilities of three cell lines by comparing 
to their control conditions. The highest concentration (1μM) of THG showed the lowest 
viability for all cell lines (Figure 4.2). 
 
Figure 4.2. Dose-dependent effect of THG treatment. Cells were seeded as 4000 cell/well 
for three different cell lines and treated with THG for 48 hours with indicated concentrations. 
Cell viability was measured by WST-1 Cell Proliferation assay (Roche) according to 
manufacturer’s protocol. Histogram results represent the mean values ± SEM. Viability value 
of control condition (CNT, no treatment) was taken as 100 and remaining values were 
calculated accordingly. *P<0.05 versus CNT. 
 
Increasing time of THG exposure (4, 8, 16, 24 and 48 hours) revealed a gradually decrease 
in viability of MCF7, SK-BR-3 and MDA-MB-468 cells (Figure 4.3). All cell viability results 
indicate that THG has a lethal effect in different concentrations and exposure times for three 
cell lines. Thus, we determined the THG dose and exposure times which we will perform in 
our future experiments. 
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Figure 4.3. Time-dependent effect of THG treatment. Cells were seeded as 4000 cell/well 
for three different cell lines and treated with THG for 4h, 8h, 16h, 24h and 48h with 100nM 
final concentration of THG. Cell viability was measured by WST-1 Cell Proliferation assay 
(Roche) according to manufacturer’s protocol. Histogram results represent the mean values 
± SEM. Control condition (CNT, no treatment) was taken as 100% viable and other values 
were set to their corresponded percentages, accordingly. *P<0.05 versus CNT. 
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4.3. Regulation of CANT1 Protein Expression by Thapsigargin 
CANT1 is an ER-located protein 103. Since Thapsigargin causes ER stress by disrupting Ca+2 
homeostasis in ER 29, and CANT1 uses Ca+2 as an activator for its enzymatic status 100, we 
wanted to learn if THG treatment in different concentrations and time periods has an effect 
on CANT1 protein expression level in MCF7, SK-BR-3 and MDA-MB-468 cells. Therefore, 
immunoblotting experiments were conducted.  
4.3.1. Dose-dependent Effect of THG on CANT1 Protein Expression Level 
Three different concentrations (10nM, 100nM and 1μM) of THG were tested for 48 hours in 
three different cell lines. CANT1 signals in blots were normalized according to their 
corresponded Actin bands in ImageJ software (Figure 4.4). As results of normalization were 
indicated in histograms, CANT1 protein level was gradually downregulated by increasing 
doses of THG in MCF7 and MDA-MB-468 cells. However, CANT1 protein expression in 
SK-BR-3 did not change dramatically and gradually by comparing to the results of other two 
cell lines. 
 
Figure 4.4. Effect of THG with different concentrations on CANT1 protein expression 
level. MCF7, SK-BR-3 and MDA-MB-468 cells were treated with THG for 48 hours. Final 
concentrations of THG were indicated. 30 μg total protein was loaded for each cell line. β – 
Actin is loading control and CNT represents untreated-control condition. Histograms show 
the percentage of CANT1 protein expression level which was normalized to corresponded 
CNT 10nM 100nM 1uM CNT 10nM 100nM 1uM
20
25
30
35
40
CA
NT
1 
pr
ot
ein
 e
xp
re
ss
io
n 
%
(n
or
m
ali
ze
d 
to
 A
ct
in
)
CNT 10nM 100nM 1uM
20
25
30
35
40
CA
NT
1 
pr
ot
ein
 e
xp
re
ss
io
n 
%
(n
or
m
ali
ze
d 
to
 A
ct
in
)
20
25
30
35
40
CA
NT
1 
pr
ot
ein
 e
xp
re
ss
io
n 
%
(n
or
m
ali
ze
d 
to
 A
ct
in
)
C
A
N
T1
 e
xp
re
ss
io
n 
%
(n
or
m
al
iz
ed
 t
o 
A
ct
in
)
CANT1
Actin
MCF7 SK-BR-3 MDA-MB-468
 37 
Actin expression level. Molecular weight of Actin and CANT1 is 43 kDa and 40-45 kDa, 
respectively. 
4.3.2. Time-dependent Effect of THG on CANT1 Protein Expression Level 
After we obtained the results which indicate THG is able to change the expression behavior 
of CANT1 in protein level, we decided to observe whether the duration of THG exposure 
changes CANT1 protein expression level. Therefore, MCF7, SK-BR-3 and MDA-MB-468 
cells were treated with THG (Cfinal=100nM) for time periods of 4h, 8h, 16h, 24h and 48h. 
CANT1 signals in blots were normalized according to their corresponded Actin bands by 
ImageJ software. Normalized CANT1 protein expression results are shown in histograms 
(Figure 4.5). As a result, CANT1 protein level reduced gradually by increased exposure time 
of THG in MCF-7 and MDA-MB-468 cells, and maximum reduction in protein levels were 
detected in 48h for both cell lines. The change of protein level in SK-BR-3 did not follow a 
regular pattern.  
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Figure 4.5. Effect of exposure time of THG on CANT1 protein expression level. MCF7, 
SK-BR-3 and MDA-MB-468 cells were treated with THG (Cfinal=100nM) for 4, 8, 16, 24 
and 48 hours. 30 μg total protein was loaded for each cell line. CNT represents untreated-
control condition. Histograms show the percentage of CANT1 protein expression which was 
normalized to corresponded Actin (loading control) expression levels. Molecular weight of 
Actin and CANT1 is 43 kDa and 40-45 kDa, respectively. 
4.4. Effect of Thapsigargin on the Expression of CANT1 mRNA 
Since THG can change CANT1 protein expression pattern in both dose- and time-dependent 
manner, next step was to check if THG can alter the expression of CANT1 mRNA. THG 
(100nM) was given to cells for 4h, 8h, 16h, 24h and 48h time periods. Total RNA of six 
different conditions from three cell lines were collected, and real-time RT-PCR experiments 
were carried out for gene expression quantification. The housekeeping gene GAPDH was 
used as a control. The target gene expressions were normalized by GAPDH expression levels. 
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Histograms show the fold change of relatively quantified CANT1 mRNA expression levels 
of three independently performed experiments (Figure 4.6). The significance of fluctuations 
in mRNA levels were tested statistically. Test results did not indicate any significant change 
in MCF7 and MDA-MB-468 cells. Only the fold change between the control and 48h THG 
treatment in SK-BR-3 cells is considered as significant (p<0.01). 
 
Figure 4.6. Effect of THG on the expression of CANT1 mRNA. Cells were treated with 
THG (Cfinal=100nM) for various time periods. Total RNAs from each cell line were isolated 
and real-time RT-PCR was performed to analyze CANT1 gene expression. GAPDH was 
used as a housekeeping control to normalize corresponded CANT1 levels. CNT is untreated-
control condition. Histograms expresses the mean values (± SEM) of three independent 
experiments for each cell line; **P<0.01 versus control condition. 
4.5. Subcellular Localization of CANT1 Protein in Breast Cancer Cell Lines 
It was previously reported that CANT1 is an ER-resident protein 103. To observe the 
subcellular localization of CANT1 protein in MCF7, SK-BR-3 and MDA-MB-468 cells, we 
conducted immunofluorescence experiments. We stained mitochondria (Figure 4.7) and 
endoplasmic reticulum (Figure 4.8) to identify the intracellular distribution of CANT1 
protein in breast cancer cells. Then, other steps of immunofluorescence were performed as it 
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is described in Methods section. Immunodetection of CANT1 protein was provided by a 
secondary antibody conjugated to Alexa Fluor 488 fluorochrome and displayed in green 
channel. 
 
Figure 4.7. Mitochondria staining to observe subcellular localization of CANT1 protein 
in MCF7, SK-BR-3 and MDA-MB-468 cells. Immunostaining of cells were performed to 
observe intracellular position of CANT1 protein. Mitochondria (red) and nucleus (blue) were 
stained with Mito-Tracker Red (Cfinal=100nM) and DAPI, respectively. The staining of 
CANT1 protein was followed by secondary antibody conjugated to Alexa Fluor 488 
fluorochrome. Images were taken by 63x objective in confocal laser scanning microscope. 
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Figure 4.8. Endoplasmic reticulum staining to observe subcellular localization of 
CANT1 in MCF7, SK-BR-3 and MDA-MB-468 cells. Immunostaining of cells was 
performed to observe intracellular position of CANT1 protein. Endoplasmic reticulum (red) 
and nucleus (blue) were stained with ER-Tracker Red (Cfinal=500nM) and DAPI, 
respectively. The staining of CANT1 protein was followed by secondary antibody conjugated 
to Alexa Fluor 488 fluorochrome. Images were taken by 63x objective in confocal laser 
scanning microscope. 
4.6. Examining Intracellular Localization of CANT1 Protein Under Thapsigargin 
Exposure 
Disruption of ER homeostasis is followed by activation of ER stress 9. We induced ER stress 
with THG, and we observed changes in CANT1 expression in protein level. However, we 
also wanted to learn how CANT1 localization can be affected during ER stress activation. 
To answer this question, we treated breast cancer cells with THG for 4 hours and 8 hours, 
and we monitored and analyzed subcellular localization of CANT1 protein due to THG 
treatment.  
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4.6.1. Effect of Thapsigargin on CANT1-Mitochondria Colocalization 
First, we examined CANT1-mitochondria colocalization. THG (Cfinal=100nM) was given to 
MCF7, SK-BR-3 and MDA-MB-468 cells for 4 hours and 8 hours. Mitochondria was stained 
with MitoTracker Red (Cfinal=100nM). Immunofluorescence protocol was followed and 
CANT1 protein was detected with secondary antibody conjugated to Alexa Fluor 488. 
Images were captured in confocal laser scanning microscope. Colocalization of CANT1 and 
mitochondria were analyzed in CoLocalizer Pro software as two channels, green channel for 
CANT1 and red channel for mitochondria. Merged channels and pixel scatter-grams are 
shown in Figure 4.9. Analysis results revealed two different coefficient, Pearson’s 
Correlation Coefficient (Rr) and Manders’ Overlap Coefficient (R) (Table 4.1), which 
calculates pixel densities of two channel and gives colocalization ratio 114. Mean values ± 
SEM of Manders’ Overlap Coefficient for three cell lines were displayed in histograms in 
Figure 4.10. Statistical tests were conducted to compare difference between mean values of 
control and treatment conditions in MCF7, SK-BR-3 and MDA-MB-468 cell lines, however 
one-way ANOVA test did not indicate any significant difference (P>0.05). Consequently, 
THG treatment did not affect the change in the colocalization of CANT1 and mitochondria 
significantly. 
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Figure 4.9. Colocalization 
analysis of CANT1 and 
mitochondria in MCF7, 
SK-BR-3 and MDA-MB-
468 cells. THG 
(Cfinal=100nM) was given to 
three different cells for 4 
hours or 8 hours. Confocal 
images were taken by 63x 
objective in laser scanning 
microscope. Colocalization 
analysis of CANT1 (green) 
and mitochondria (red) was 
performed by CoLocalizer 
Pro software. Scatter-grams 
were placed upper-left of 
each image. CNT indicates 
untreated cells.  
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CANT1-
Mitochondria 
Colocalization 
THG treatment Pearson’s 
Correlation 
Coefficient (Rr) 
Manders’ 
Overlap 
Coefficient (R) 
MCF7 No treatment -0.0074 0.2381 
0.1556 0.2933 
-0.0170 0.3317 
4h THG treatment -0.0018 0.2923 
-0.0024 0.0834 
-0.0343 0.0908 
0.1284 0.2603 
0.0308 0.1277 
0.1271 0.1546 
8h THG treatment 0.0608 0.1881 
-0.0802 0.3729 
-0.1162 0.2661 
-0.0895 0.2855 
-0.1329 0.2521 
0.0712 0.2198 
SK-BR-3 No treatment -0.0388 0.1728 
0.0695 0.3219 
0.0335 0.3328 
0.0784 0.3170 
-0.1515 0.2509 
0.0232 0.2951 
4h THG treatment 0.1519 0.5487 
-0.0550 0.4715 
0.0544 0.4032 
0.2557 0.4689 
8h THG treatment 
 
 
 
 
0.1575 0.5350 
0.0797 0.3595 
0.0787 0.2311 
0.0500 0.1465 
0.1809 0.5434 
 45 
 
Table 4.1. Pearson’s Correlation Coefficient (Rr) and Manders’ Overlap Coefficient 
(R) that were revealed by colocalization analysis of CANT1 and mitochondria. 
MDA-MB-468 No treatment 0.0382 0.1695 
0.0474 0.2217 
0.1083 0.2197 
-0.0487 0.1682 
0.1030 0.3385 
4h THG treatment 0.1380 0.3946 
0.0888 0.2869 
0.0663 0.2458 
8h THG treatment 0.0714 0.1865 
0.1445 0.3702 
0.0269 0.1088 
0.0565 0.3277 
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Figure 4.10. Colocalization of CANT1 and mitochondria according to Manders’ 
Overlap Coefficient. MCF7, SK-BR-3 and MDA-MB-468 cells were treated with THG 
(Cfinal=100nM) for 4 hours and 8 hours. Colocalization was analyzed by CoLocalizer Pro 
software and, analysis revealed Manders’ Overlap Coefficient values. Histograms show 
mean value ± SEM of Manders’ Overlap Coefficient. CNT is untreated-control condition. 
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4.6.2. Effect of Thapsigargin on CANT1-Endoplasmic Reticulum Colocalization 
Next, we studied CANT1-ER colocalization pattern under THG exposure. After cells treated 
with THG (Cfinal=100nM) for 4 hours and 8 hours, ER was stained with ER-Tracker Red 
(Cfinal=500nM), and immunofluorescence protocol was followed. CANT1 protein was 
detected with secondary antibody conjugated to Alexa Fluor 488 fluorochrome. Confocal 
images were photographed in laser scanning microscope and they were analyzed by 
CoLocalizer Pro software. Colocalization analysis was performed by measuring pixel 
densities of two channels, green channel (CANT1) and red channel (ER).  Merged channels 
with pixel scatter-grams were shown in Figure 4.11 for MCF7, in Figure 4.12 for SK-BR-3 
and in Figure 4.13 MDA-MB-468 cells. Colocalization coefficients were listed in Table 4.2. 
Quantification of Manders’ Overlap Coefficient for three cell lines were displayed in 
histograms (Figure 4.14.). Here, statistical tests were conducted to detect significance in 
differences between conditions (CNT, 4h, 8h). According to the results of statistical tests, 
CANT1 and ER colocalization changes in MCF7 and MDA-MB-468 cell lines significantly 
due to THG treatment (*P<0.05, **P<0.01 and ***P<0.001).  THG treatment did not exhibit 
any significant effect on the change of CANT1-ER colocalization in SK-BR-3 cell line 
(P>0.05). 
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Figure 4.11. CANT1-ER colocalization analysis in MCF7 cells. Cells were treated with 
THG (Cfinal=100nM) for 4 hours or 8 hours. Confocal images were taken by 63x objective in 
laser scanning microscope. Colocalization analysis of CANT1 (green) and ER (red) was 
performed by CoLocalizer Pro software. Scatter-grams were placed upper-left of each image. 
CNT indicates untreated cells. 
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Figure 4.12. CANT1-ER colocalization analysis in SK-BR-3 cells. Cells were treated with 
THG (Cfinal=100nM) for 4 hours or 8 hours. Confocal images were taken by 63x objective in 
laser scanning microscope. Colocalization analysis of CANT1 (green) and ER (red) was 
performed by CoLocalizer Pro software. Scatter-grams were placed upper-left of each image. 
CNT indicates untreated cells. 
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Figure 4.13. CANT1-ER colocalization analysis in MDA-MB-468 cells. Cells were treated 
with THG (Cfinal=100nM) for 4 hours or 8 hours. Confocal images were taken by 63x 
objective in laser scanning microscope. Colocalization analysis of CANT1 (green) and ER 
(red) was performed by CoLocalizer Pro software. Scatter-grams were placed upper-left of 
each image. CNT indicates untreated cells.  
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CANT1-ER 
Colocalization 
 
THG 
treatment 
Pearson’s 
Correlation 
Coefficient (Rr) 
Manders’ 
Overlap 
Coefficient (R) 
MCF7 No treatment 0.0559 0.4157 
0.1018 0.5777 
0.2009 0.4686 
-0.1759 0.2883 
0.0556 0.3198 
0.1874 0.1923 
0.1394 0.4011 
4h THG treatment 0.2595 0.4430 
0.4800 0.6086 
0.4260 0.5073 
0.4049 0.6105 
0.3371 0.4820 
8h THG treatment 0.4049 0.6105 
0.5653 0.5800 
0.4697 0.5004 
0.6430 0.7222 
0.6102 0.6959 
SK-BR-3 
 
 
 
 
 
 
 
 
 
 
 
No treatment 0.0788 0.2247 
0.0286 0.4009 
0.1094 0.2246 
0.0867 0.2164 
0.1612 0.2727 
4h THG treatment -0.0910 0.1540 
0.1149 0.3779 
0.2775 0.2973 
0.2809 0.3151 
0.3472 0.4720 
0.0867 0.2164 
8h THG treatment 0.1899 0.2733 
0.0640 0.2766 
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Table 4.2. Pearson’s Correlation Coefficient (Rr) and Manders’ Overlap Coefficient 
(R) that were revealed by colocalization analysis of CANT1 and endoplasmic reticulum. 
 
 
 
SK-BR-3 8h THG treatment 0.1169 0.3880 
0.1177 0.4781 
0.1801 0.5904 
MDA-MB-468 
 
 
 
 
 
 
 
 
 
 
 
No treatment 0.0728 0.3365 
0.1034 0.2110 
-0.0339 0.1877 
-0.0559 0.1084 
0.0287 0.1494 
-0.0673 0.2117 
-0.0052 0.1899 
0.1693 0.1843 
0.1532 0.1943 
4h THG treatment 
 
 
0.0610 0.3308 
0.0240 0.1608 
-0.1431 0.1970 
0.0500 0.3880 
0.1544 0.3571 
0.1250 0.3334 
8h THG treatment 0.4247 0.6217 
0.5740 0.4265 
0.3313 0.2892 
0.5965 0.5595 
0.4059 0.4628 
0.4309 0.3207 
 53 
 
Figure 4.14. Colocalization of CANT1 and endoplasmic reticulum according to 
Manders’ Overlap Coefficient. MCF7, SK-BR-3 and MDA-MB-468 cells were treated 
with THG (Cfinal=100nM) for 4 hours and 8 hours. CNT is untreated-control condition. 
Colocalization was analyzed by CoLocalizer Pro software, and analysis revealed Manders’ 
Overlap Coefficient values. Histograms show mean value ± SEM of Manders’ Overlap 
Coefficient; *P<0.05, **P<0.01 and ***P<0.001 versus control condition.
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5. DISCUSSION 
The ER has fundamental roles in the cell, such as translation, protein modification, protein 
quality control, secretion of proteins, lipid biosynthesis and calcium storage. Maintenance of 
ER homeostasis is required for cell health and survival 1. ER mechanisms can be affected by 
external and internal factors that disrupts ER homeostasis and cause ER stress. The protective 
mechanism unfolded protein response (UPR) is activated to manage ER stress. If the stress 
does not exceed, UPR handles this stress and reestablishes ER homeostasis back to contribute 
to cell survival. However, if the stress is prolonged and causes severe damage, UPR 
downstream activates apoptotic cell death signaling 9, 10 . 
Calcium-activated nucleotidase 1 (CANT1) is a nucleotide hydrolyzing enzyme which 
belongs to apyrase family. It is responsible for the converting of extracellular nucleoside di-
and triphosphates into nucleoside monophosphates 100. The mutation in CANT1 gene is 
associated to Desbuquois dysplasia which is an autosomal recessive disorder revealing 
skeletal growth abnormalities in joints, hands and femur 104, 105. The role of CANT1 in 
Desbuquois dysplasia in not unclear but there is a proposed mechanism about the 
involvement of CANT1 in the proteoglycan metabolism in the case of Desbuquois dysplasia 
107.  
In human, prostate is one of the tissues in which CANT1 mRNA is expressed highly 100. 
Upon this knowledge, the expression and regulation of CANT1 has been studied previously 
in the prostate cancer cells 109, 110. CANT1 expression in breast cancer cells was mentioned 
in one study indicating CANT1, as a phosphatase, is under-expressed in the estrogen negative 
breast cancer cell lines in comparison to estrogen positive cell lines 118. In the construction 
of this thesis, we aimed to identify the regulation of CANT1 in breast cancer cell lines during 
ER stress-induced cell death. 
Firstly, in order to have an idea about the expression of CANT1 protein in breast cancer cell 
lines, we screened forty breast cancer cell lines, four normal breast epithelial cell lines and 
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one prostate cancer cell line (PC3) to analyze CANT1 protein expression patterns by 
immunoblotting (Figure 4.1). Because it was reported that CANT1 is overexpressed 
endogenously in prostate cancer 100, 109, 110, we preferred to use it as a positive control. Our 
screening results revealed different expression patterns. The molecular weight of CANT1 
protein was between 40-45 kDa among cell lines. The number of detected band signals was 
also showed diversity. We observed three separated signals that have different molecular 
weights from 40 kDa to 45 kDa. The reason of this variety can be that the alternatively spliced 
forms of CANT1 protein might show different characteristics among cell lines. In other 
words, different breast cancer cell lines are able to splice CANT1 mRNA differently to 
generate variant forms of the protein. Another reason of this might be related to post-
translation modifications of CANT1 protein. Smith et al. showed that CANT1 is a 
glycosylated protein. They observed that signal of CANT1 shifted to lower kDa in western 
blot analysis after they deglycosylate the protein by PNGase F 100, meaning that detected 
signals in different molecular weights can be caused by post-translational modifications. 
Other post-translational modifications can be investigated to clarify why and how the 
different number of protein signals with different molecular weight in immunoblot detection 
were obtained.  
In the screening results, CANT1 protein was found to be expressed relatively high in SK-
BR-3, HCC-1419, MDA-MB-415, UACC-983, MDA-MB-175-7 and MDA-MB-134-6 cell 
lines. The expression pattern of these cell lines was two bands with approximately same 
signal intensity. There are also cell lines such as HCC-70, HCC-202, HCC-1937, HCC-1954, 
HCC-2157 and ZR-75-1 that have one band signal is more intense than the other band. A 
third band, the soluble variant of CANT1, has emerged in HCC-202 and HCC-2218 cell lines. 
We decided to study with SK-BR-3, MCF7 and MDA-MB-468 for our further experiments. 
Detected protein levels in MDA-MB-468 and MCF7 cells were relatively less when we 
compared to those of SK-BR-3. Addition to that, we think the receptors that are expressed 
on these cell lines might be important because studies showed that CANT1 is an androgen-
regulated protein in prostate cancer 109, 110. Therefore, the hormonal regulation of CANT1 in 
breast cancer can be operated by receptor expression. HER2, estrogen and progesterone 
receptor status of these cell lines are HER2+, ER-, PR- for SK-BR-3, HER2-, ER+, PR+ for 
MCF7 and HER2-, ER-, PR- for MDA-MB-468 116, 117. 
 56 
Thapsigargin (THG) was used to generate ER stress. Next step was to determine dose and 
exposure time of THG in breast cancer cell lines. MCF7, SK-BR-3 and MDA-MB-468 cells 
were treated with THG in dose-dependent (10nM, 100nM and 1μM) and time dependent 
manner (4h, 8h, 16h, 24h and 48h). The effect of THG on the viabilities of breast cancer cell 
lines was assessed by a proliferation assay. In the dose dependent case, even the lowest 
concentration of THG (10nM) caused the death of almost 50% of the cells in all three cell 
lines (Figure 4.2). For time-dependent case (Figure 4.3), the increasing exposure time of THG 
caused a gradual reduction in the viability of three cell lines, as it was expected. However, 
this reduction of viability among cell lines show variety. For instance, in MCF7 cells, cell 
viability was detected around 85% from 4h to 24h treatments. However, detected cell 
viability was decreased to 70% at 48h in MCF7 while SK-BR-3 and MDA-MB-468 cells 
showed sharper reduction in cell death after 16h of treatment. This is because different cell 
lines response and progress ER stress-induced apoptotic cell death signaling differently. 
These differences can be related to the THG exposure time which rules the transition of UPR 
from cytoprotective mode to killer mode. To elaborate this transition, we can perform 
additional cell death detection assays in our future works, as in one study examining 
apoptosis initiation by THG in MCF7 and MDA-MB-468 cell lines 119. 
The way that THG cause ER stress is the disruption of calcium homeostasis by inhibiting 
SERCA pumps which are responsible for the transportation of cytosolic calcium into ER 29. 
Since CANT1 is an ER-resident protein, and calcium is responsible for not only enzymatic 
activation of CANT1 but also the structural stability and conformation 102, we wanted to learn 
how CANT1 protein level is affected during ER stress-induced cell death. According to the 
previously determined doses (10nM, 100nM and 1μM; for 48h) and exposure times (4h, 8h, 
16h, 24h and 48h; with 100nM) of THG, we treated MCF7, SK-BR-3 and MDA-MB-468 
cells and performed immunoblotting experiments to detect protein levels. Figure 4.4 shows 
the effect of different concentrations of THG on the CANT1 protein expression. Increasing 
dose of THG caused an apparent reduction of protein levels in MCF7 and MDA-MB-468 
cells. However, CANT1 protein level in SK-BR-3 fluctuated and did not follow a regular 
pattern through ER stress activation.  
CANT1 protein was also downregulated in MCF and MDA-MB-468 cell lines by the 
increased exposure time (Figure 4.5). The regulation of protein level in SK-BR-3 did not 
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follow a pattern like these of MCF7 and MDA-MB-468 cell lines. Addition to that, SK-BR-
3 immunoblot result (Figure 4.5) revealed a third band (36-38 kDa) which is probably the 
soluble form of CANT1 as it was reported before 100, 101.  
In both dose- and time-dependent treatments, CANT1 protein levels in SK-BR-3 cell line did 
not change dramatically and gradually like two other cell lines. The reason for this case might 
be related to the protein turnover rate of SK-BR-3 cells. Among three cell lines, SK-BR-3 is 
the only cell line which expresses HER2 receptor. To answer the question if it is receptor 
status-dependent or not, CANT1 expression patterns in other HER2+ breast cancer cell lines 
can be studied in the future.  
Since we observed changes in CANT1 protein expression by THG-mediated ER stress, we 
also wanted to observe how CANT1 mRNA expression levels change upon THG treatment. 
Cells were treated with THG (100nM) for various time periods. Gene expression 
quantification of CANT1 was performed and results are shown in Figure 4.6. Obtained data 
was statistically tested. However, changes in the mRNA expression levels in MCF7 and 
MDA-MB-468 cell lines are not considered as significant according to statistical tests that 
we conducted. Only detected significant difference was between the control and 48h 
treatment of SK-BR-3 cells.  Our findings suggest that protein expression alterations are not 
affected in transcriptional level. Therefore, we can hypothesize that the regulation of CANT1 
expression during ER stress is a protein level-dependent process. In our future studies, we 
would like to focus on the protein processing mechanisms such as translation, post-
translational modifications, protein activation and transport. 
It is known that CANT1 is an ER-resident protein. Additionally, CANT1 was also detected 
at ER-Golgi transition regions by immunocytochemical assays 103. In the Figure 4.7 and 
Figure 4.8, we stained mitochondria and ER, respectively, and we wanted to observe the 
subcellular localization of CANT1 in the breast cancer cell lines through the stained organelle 
references. CANT1 protein is detected in close proximity to nucleus, indicating a localization 
at ER or ER-Golgi transition sites. However, we also observed the distribution of CANT1 
protein across the cell, most probably the fixation and staining steps of immunofluorescence 
synchronized with translation or transportation processes of the protein in the cell.  
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After that, we investigated the effect of THG on the subcellular localization of CANT1. 
Therefore, we conducted colocalization analysis. In Figure 4.9, confocal imaging of CANT1-
mitochondria staining as merged channels is shown. Coefficients that were obtained from 
performed colocalization analysis were statistically tested to determine if the changes upon 
the treatment are significant or not. Our results suggest that THG does not affect CANT1-
mitochondria colocalization significantly (Figure 4.10).  
As a next step, ER was stained for colocalization analysis in breast cancer cell lines. Confocal 
microscopy images of merged channels were shown in Figure 4.11 for MCF7, in Figure 4.12 
for SK-BR-3 and in Figure 4.13 MDA-MB-468 cells with pixel scatter-grams. The results of 
colocalization analysis were quantified (Figure 4.14). We notice that CANT1 and ER 
colocalization correspondingly revealed an increasing pattern with the increased time of 
THG exposure. According to the statistical tests that we conducted, the increasing in the 
colocalization of CANT1 and ER is found significant in MCF7 and MDA-MB-468 cell lines. 
However, the observed change of CANT1-ER colocalization in SK-BR-3 is not significant 
(P>0.05). The increase in the localization to ER upon stress might offer a role for CANT1 
regarding the regulation of UPR since it is reported that APY-1, the Caenorhabditis elegans 
homologue of CANT1, involves in UPR signaling in the nematode 112. Another study 
reported that CANT1 may contribute to protein synthesis and degradation, and it may control 
calcium homeostasis since CANT1 overexpression increases Ca+2 level in the Golgi 111. 
These suggested roles for CANT1 can present possible functions that are related to ER 
mechanisms. 
In summary, we investigated the regulation of CANT1 in breast cancer cells that undergoing 
ER stress or initiating apoptotic cell death. We showed that the regulation of CANT1 protein 
is cell subtype-dependent. In the literature, the number of studies that are related to CANT1 
is limited, and also the studies focus on different approaches. Our aim was to identify the role 
and the regulation of CANT1 protein in breast cancer during ER stress-related cell death, 
which has not been reported before. This study and the findings have generated many 
questions for the future of our research. First of all, we would like to clarify the reasons and 
mechanisms behind the number of protein signal bands detected in our immunoblot results. 
We can check if this case is related to post-translational modifications or not. If these 
differences are related to alternative splicing processing, then we can delete exons or intron-
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exon junctions by gene editing methods to explain their importance and functions. 
Furthermore, in order to identify the role of CANT1 in ER or in the cell, we can conduct 
protein-protein interaction studies. The activation of caspases and UPR downstream elements 
can be monitored to check the regulation of CANT1 during ER stress-induced cell death. 
Furthermore, to define a more general role for CANT1, other breast cancer cell subtypes can 
be studied. 
 60 
6. REFERENCES 
1.  Schwarz DS, Blower MD. The endoplasmic reticulum: Structure, function and 
response to cellular signaling. Cell Mol Life Sci. 2016;73(1):79-94. 
doi:10.1007/s00018-015-2052-6. 
2.  Braakman I, Hebert DN. Protein folding in the endoplasmic reticulum. Cold Spring 
Harb Perspect Biol. 2013;5(5). doi:10.1101/cshperspect.a013201. 
3.  Braakman I, Bulleid NJ. Protein Folding and Modification in the Mammalian 
Endoplasmic Reticulum. Annu Rev Biochem. 2011;80(1):71-99. doi:10.1146/annurev-
biochem-062209-093836. 
4.  Ellgaard L, McCaul N, Chatsisvili A, Braakman I. Co- and Post-Translational Protein 
Folding in the ER. Traffic. 2016;17(6):615-638. doi:10.1111/tra.12392. 
5.  Xu C, Ng DTW. Glycosylation-directed quality control of protein folding. Nat Rev 
Mol Cell Biol. 2015;16(12):742-752. doi:10.1038/nrm4073. 
6.  Bulleid NJ. Disulfide bond formation in the mammalian endoplasmic reticulum. Cold 
Spring Harb Perspect Biol. 2012;4(11):1-12. doi:10.1101/cshperspect.a013219. 
7.  Ellgaard, Lars and Helenius A. ER quality control: towards an understanding at the 
molecular level. Curr Opin Cell Biol. 2001;13:431-437. 
8.  Fagone P, Jackowski S. Membrane phospholipid synthesis and endoplasmic reticulum 
function. J Lipid Res. 2009;50(Supplement):S311-S316. doi:10.1194/jlr.R800049-
JLR200. 
9.  Shen X, Zhang K, Kaufman RJ. The unfolded protein response: A stress signaling 
pathway of the endoplasmic reticulum. J Chem Neuroanat. 2004;28(1-2):79-92. 
doi:10.1016/j.jchemneu.2004.02.006. 
10.  Hetz C. The unfolded protein response: Controlling cell fate decisions under ER stress 
and beyond. Nat Rev Mol Cell Biol. 2012;13(2):89-102. doi:10.1038/nrm3270. 
11.  Gething M. Role and regulation of the ER chaperone BiP. Cell Dev Biol. 1999;10:465-
472. 
12.  Walter P, David R. The Unfolded Protein Response: From stress pathway to 
homeostatic regulation. Science (80- ). 2011;334(6059):1081-1086. 
doi:10.1126/science.1209038. 
13.  Adachi Y, Yamamoto K, Okada T, Yoshida H, Harada A. ATF6 Is a Transcription 
Factor Specializing in the Regulation of Quality Control Proteins in the Endoplasmic 
Reticulum. Cell Struct Funct. 2008;33:75-89. 
14.  Chen X, Shen J, Prywes R. The Luminal Domain of ATF6 Senses Endoplasmic 
 61 
Reticulum (ER) Stress and Causes Translocation of ATF6 from the ER to the Golgi. 
J Biol Chem. 2002;277(15):13045-13052. doi:10.1074/jbc.M110636200. 
15.  Sano R. and Reed J. ER stress-induced cell death mechanisms. Biochim Biophys Acta. 
2014;1833(12):1-26. doi:10.1016/j.bbamcr.2013.06.028.ER. 
16.  Harding HP, Zhang Y, Ron D, Harding HP, Zhang Y, Ron D. Protein translation and 
folding are coupled by an endoplasmic reticulum-resident kinase. Nature. 
1999;398(March):271-274. 
17.  Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. Perk Is Essential for Translational 
Regulation and Cell Survival during the Unfolded Protein Response. Mol Cell. 
2000;5:897-904. 
18.  Harding HP, Novoa I, Zhang Y, et al. Regulated Translation Initiation Controls Stress-
Induced Gene Expression in Mammalian Cells. Mol Cell. 2000;6:1099-1108. 
19.  Zinszner H, Kuroda M, Wang X, et al. CHOP is implicated in programmed cell death 
in response to impaired function of the endoplasmic reticulum. Genes Dev. 
1998;12:982-995. 
20.  Wang X, Kuroda M, Sok J, et al. Identification of novel stress-induced genes 
downstream of chop. EMBO J. 1998;17(13):3619-3630. 
21.  Cullough KDMC, Martindale JL, Klotz L, Aw T, Holbrook NJ. Gadd153 Sensitizes 
Cells to Endoplasmic Reticulum Stress by Down-Regulating Bcl2 and Perturbing the 
Cellular Redox State. Mol Cell Biol. 2001;21(4):1249-1259. 
doi:10.1128/MCB.21.4.1249. 
22.  Tirasophon W, Welihinda AA, Kaufman RJ. A stress response pathway from the 
endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase / 
endoribonuclease (Ire1p) in mammalian cells. Genes Dev. 1998;12:1812-1824. 
23.  Shamu CE, Walter P. Oligomerization and phosphorylation of the Irelp kinase during 
intracellular signaling from the endoplasmic reticulum to the nucleus. EMBO J. 
1996;15(12):3028-3039. 
24.  Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA Is Induced by 
ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active 
Transcription Factor. Cell. 2001;107:881-891. 
25.  Orr HA, Coyne JA, Mackay TFC, et al. Decay of Endoplasmic Reticulum-Localized 
mRNAs During the Unfolded Protein Response. Science (80- ). 2006;313(July):104-
108. 
26.  Han D, Lerner AG, Walle L Vande, et al. IRE1α Kinase Activation Modes Control 
Alternate Endoribonuclease Outputs to Determine Divergent Cell Fates. Cell. 
2010;138(3):562-575. doi:10.1016/j.cell.2009.07.017.IRE1. 
27.  Urano F, Wang X, Bertolotti A, et al. Coupling of Stress in the ER to Activation of 
JNK Protein Kinases by Transmembrane Protein Kinase IRE1. Science (80- ). 
2000;287(January):664-667. 
28.  Andersen TB, López CQ, Manczak T, Martinez K, Simonsen HT. Thapsigargin-From 
Thapsia L. to Mipsagargin. Molecules. 2015;20(4):6113-6127. 
 62 
doi:10.3390/molecules20046113. 
29.  Lytton J, Westlin M, Hanley MR. Thapsigargin inhibits the sarcoplasmic or 
endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem. 
1991;266(26):17067-17071. doi:VL  - 266. 
30.  Doan NTQ, Paulsen ES, Sehgal P, et al. Targeting thapsigargin towards tumors. 
Steroids. 2015;97:2-7. doi:10.1016/j.steroids.2014.07.009. 
31.  Periasamy M, Kalyanasundaram A. SERCA pump isoforms: Their role in calcium 
transport and disease. Muscle and Nerve. 2007;35(4):430-442. 
doi:10.1002/mus.20745. 
32.  Dubois C, Vanden Abeele F, Sehgal P, et al. Differential effects of thapsigargin 
analogues on apoptosis of prostate cancer cells: complex regulation by intracellular 
calcium. Febs J. 2013;280(21):5430-5440. doi:10.1111/febs.12475. 
33.  Sehgal P, Szalai P, Olesen C, et al. Inhibition of the sarco/endoplasmic reticulum (ER) 
Ca2+-ATPase by thapsigargin analogs induces cell death via ER Ca2+ depletion and 
the unfolded protein response. J Biol Chem. 2017:jbc.M117.796920. 
doi:10.1074/jbc.M117.796920. 
34.  Denmeade SR, Jakobsen CM, Janssen S, et al. Prodrug as Targeted Therapy for 
Prostate Cancer. J Natl Cancer Inst. 2018;95(13). 
35.  Brennen WN, Rosen DM, Wang H, Isaacs JT, Denmeade SR. Targeting Carcinoma-
Associated Fibroblasts Within the Tumor Stroma With a Fibroblast Activation 
Protein-Activated Prodrug. J Nat Cancer Inst. 2018;104(17):19-21. 
doi:10.1093/jnci/djs336. 
36.  Takatsuki, A., Arima, K., and Tamura G. Tunicamycin, a new antibiotic. I. Isolation 
and characterization of tunicamycin. J Antibiot (Tokyo). 1970;XXIV(4). 
37.  Elbein AD. The tunicamycins- useful tools for studies on glycoproteins. Trends 
Biochem Sci. 1981;6:219-221. 
38.  Andresen L, Skovbakke SL, Persson G, Hagemann-jensen M, Hansen KA. 2-Deoxy 
d-Glucose Prevents Cell Surface Expression of NKG2D Ligands through Inhibition 
of N -Linked Glycosylation. J Immunol. 2012;188:1847-1855. 
doi:10.4049/jimmunol.1004085. 
39.  Schönthal AH. Endoplasmic Reticulum Stress: Its Role in Disease and Novel 
Prospects for Therapy. Scientifica (Cairo). 2012;2012:1-26. 
doi:10.6064/2012/857516. 
40.  Klausner RD, Donaldson JG, Lippincott-Schwartz J. Brefeldin A: Insights into the 
Control of Membrane Traffic and Organelle Structure. J Cell Biol. 1992;116(5):1071-
1080. 
41.  Yadav RK, Chae S, Kim H, Chae HJ. Endoplasmic Reticulum Stress and Cancer. J 
Cancer Prev. 2014;19(2):75-88. 
42.  Tsai YC, Weissman AM. The Unfolded Protein Response, Degradation from the 
Endoplasmic Reticulum, and Cancer. Genes Cancer. 2010;1(7):764-778. 
doi:10.1177/1947601910383011. 
 63 
43.  Healy SJM, Gorman AM, Mousavi-shafaei P, Gupta S, Samali A. Targeting the 
endoplasmic reticulum-stress response as an anticancer strategy. Eur J Pharmacol. 
2009;625(1-3):234-246. doi:10.1016/j.ejphar.2009.06.064. 
44.  Patricia M, Sana O, Lisa K, Frank CR. Overexpression of the glucose-regulated stress 
gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res 
Treat. 2000;59:15-26. 
45.  Niu Z, Wang M, Zhou L, Yao L, Liao Q, Zhao Y. Elevated GRP78 expression is 
associated with poor prognosis in patients with pancreatic cancer. Nat Publ Gr. 
2015;5(16067):1-12. doi:10.1038/srep16067. 
46.  Mhaidat NM, Alzoubi KH, Almomani N, Khabour OF. Expression of glucose 
regulated protein 78 (GRP78) determines colorectal cancer response to chemotherapy. 
Cancer Biomarkers. 2015;15:203-209. doi:10.3233/CBM-140454. 
47.  Wang YAN, Wang JH, Zhang XUNLEI, Wang XLI, Yang LEI. Endoplasmic 
reticulum chaperone glucose ‑ regulated protein 78 in gastric cancer: An emerging 
biomarker. Oncol Lett. 2018;15:6087-6093. doi:10.3892/ol.2018.8114. 
48.  Fu W, Wu X, Li J, et al. Upregulation of GRP78 in Renal Cell Carcinoma and Its 
Significance. J Urol. 2010;75(3):603-607. doi:10.1016/j.urology.2009.05.007. 
49.  Lee HK, Xiang C, Cazacu S, et al. GRP78 is overexpressed in glioblastomas and 
regulates glioma cell growth and apoptosis. Neuro Oncol. 2008:236-243. 
doi:10.1215/15228517-2008-006. 
50.  Delie F, Petignat P, Cohen M. GRP78 protein expression in ovarian cancer patients 
and perspectives for a drug-targeting approach. J Oncol. 2012;2012:5. 
doi:10.1155/2012/468615. 
51.  Dong D, Ni M, Li J, et al. Critical role of the stress chaperone GRP78/BiP in tumor 
proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor 
development. Cancer Res. 2008;68(2):498-505. doi:10.1158/0008-5472.CAN-07-
2950. 
52.  Urra H, Dufey E, Avril T, Chevet E, Hetz C. Endoplasmic Reticulum Stress and the 
Hallmarks of Cancer. TRENDS in CANCER. 2016;2(5):252-262. 
doi:10.1016/j.trecan.2016.03.007. 
53.  Schewe DM, Aguirre-ghiso JA. ATF6a-Rheb-mTOR signaling promotes survival of 
dormant tumor cells in vivo. PNAS. 2008;105(30):10519-10524. 
54.  Hanaoka M, Ishikawa T, Ishiguro M, Tokura M. Expression of ATF6 as a marker of 
pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a 
potential role in the management of dysplasia. J Gastroenterol. 2018;53(5):631-641. 
doi:10.1007/s00535-017-1387-1. 
55.  Dadey DYA, Kapoor V, Khudanyan A, et al. The ATF6 pathway of the ER stress 
response contributes to enhanced viability in glioblastoma. Oncotarget. 
2015;7(2):2080-2092. 
56.  Wang, Y., Alam, G.N., Ning, Y., Visioli, F., Dong, Z., Nör, J.E., and Polverini PJ. The 
Unfolded Protein Response Induces the Angiogenic Switch in Human Tumor Cells 
 64 
through the PERK/ATF4 Pathway Yugang. Cancer Res. 2013;72(20):5396-5406. 
doi:10.1158/0008-5472.CAN-12-0474.The. 
57.  Notte A, Rebucci M, Fransolet M, et al. Taxol-induced unfolded protein response 
activation in breast cancer cells exposed to hypoxia: ATF4 activation regulates 
autophagy and inhibits apoptosis. Int J Biochem Cell Biol. 2015;62:1-14. 
doi:10.1016/j.biocel.2015.02.010. 
58.  Kouroku Y, Fujita E, Tanida I, et al. ER stress (PERK/eIF2 a phosphorylation) 
mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy 
formation. Cell Death Differ. 2007;1:230-239. doi:10.1038/sj.cdd.4401984. 
59.  Mujcic H, Nagelkerke A, Rouschop KMA, et al. Hypoxic Activation of the 
PERK/eIF2a Arm of the Unfolded Protein Response Promotes Metastasis through 
Induction of LAMP3. Hum Cancer Biol. 2013;19(8):6126-6138. doi:10.1158/1078-
0432.CCR-13-0526. 
60.  DeZwaan-McCabe D, Riordan JD, Arensdorf AM, Icardi MS, Dupuy AJ, Rutkowski 
DT. The Stress-Regulated Transcription Factor CHOP Promotes Hepatic 
Inflammatory Gene Expression, Fibrosis, and Oncogenesis. PLoS Genet. 2013;9(12). 
doi:10.1371/journal.pgen.1003937. 
61.  Fujimoto T, Onda M, Nagai H, Nagahata T, Ogawa K, Emi M. Upregulation and 
overexpression of human X-box binding protein 1 (hXBP-1) gene in primary breast 
cancers. Breast Cancer. 2003;10(4):301-306. 
http://www.ncbi.nlm.nih.gov/pubmed/14634507. 
62.  Koong AC, Chauhan V, Romero-Ramirez L. Targeting XBP-1 as a novel anti-cancer 
strategy. Cancer Biol Ther. 2006;5(7):756-759. doi:10.4161/cbt.5.7.2973. 
63.  Shuda M. KNYM et al. Activation of the ATF6, XBP1 and grp78 genes in human 
hepatocellular carcinoma: a possible involvement of the ER stress pathway in 
hepatocarcinogenesis. J Hepatol. 2003;38:605-614. doi:10.1016/S0. 
64.  Chen X, Iliopoulos D, Zhang Q, et al. XBP1 promotes triple-negative breast cancer by 
controlling the HIF1α pathway. Nature. 2014;508(1):103-107. 
doi:10.1038/nature13119. 
65.  Mimura N, Fulciniti M, Gorgun G, et al. Blockade of XBP1 splicing by inhibition of 
IRE1a is a promising therapeutic option in multiple myeloma. Blood. 
2012;119(24):5772-5782. doi:10.1182/blood-2011-07-366633.The. 
66.  Thorpe JA, Schwarze SR. IRE1α controls cyclin A1 expression and promotes cell 
proliferation through XBP-1. Cell Stress Chaperones. 2010;15(5):497-508. 
doi:10.1007/s12192-009-0163-4. 
67.  Li XX, Zhang HS, Xu YM, et al. Knockdown of IRE1α inhibits colonic tumorigenesis 
through decreasing α-catenin and IRE1α targeting suppresses colon cancer cells. 
Oncogene. 2017;36(48):6738-6746. doi:10.1038/onc.2017.284. 
68.  Cubillos-Ruiz JR, Glimcher LH. Targeting abnormal ER stress responses in tumors: 
A new approach to cancer immunotherapy. Oncoimmunology. 2016;5(3):1-3. 
doi:10.1080/2162402X.2015.1098802. 
 65 
69.  Rappa F, Farina F, Zummo G, et al. HSP-Molecular chaperones in cancer biogenesis 
and tumor therapy: An overview. Anticancer Res. 2012;32(12):5139-5150. 
70.  Crowley VM, Huard DJE, Lieberman RL, Blagg BSJ. Second Generation Grp94-
Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer. 
Chem - A Eur J. 2017;23(62):15775-15782. doi:10.1002/chem.201703398. 
71.  Hua Y, White-gilbertson S, Kellner J, Rachidi S, Usmani SZ. Molecular Chaperone 
gp96 Is a Novel Therapeutic Target of Multiple Myeloma. Clin Cancer Res. 
2013;19(22):6242-6252. doi:10.1158/1078-0432.CCR-13-2083. 
72.  Kerr JFR, Wyllie AH CA. Apoptosis: A Basic Biological Phenomenon With Wide-
Ranging Implications in Tissue Kinetics. Br J Cancer. 1972;26:239-257. 
73.  Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 
2007;35(4):495-516. doi:10.1080/01926230701320337. 
74.  Horvitz R, Yuan J. The Caenorhabditis elegans Genes ced-3 and ced-4 Act Cell 
Autonomously to Cause Programmed Cell Death. Dev Biol. 1990;41:33-41. 
75.  Mcilwain DR, Berger T, Mak TW. Caspase Functions in Cell Death and Disease. Cold 
Spring Harb Perspect Biol. 2013;5:5:a008656. doi:10.1101/cshperspect.a008656. 
76.  Suzanne M, Steller H. Shaping organisms with apoptosis. Cell Death Differ. 
2013;20(5):669-675. doi:10.1038/cdd.2013.11. 
77.  Schultz DR, Harrington WJ. Apoptosis: Programmed Cell Death at a Molecular Level. 
Semin Arthritis Rheum. 2003;32(6):345-369. doi:10.1053/sarh.2003.50005. 
78.  Kroemer G, Galluzzi L, Brenner C. Mitochondrial Membrane Permeabilization in Cell 
Death. Physiol Rev. 2007;87:99-163. doi:10.1152/physrev.00013.2006. 
79.  Li H, Zhu H, Xu C, Yuan J. Cleavage of BID by Caspase 8 Mediates the Mitochondrial 
Damage in the Fas Pathway of Apoptosis. Cell. 1998;94:491-501. 
80.  Shamas-din A, Kale J, Leber B, Andrews DW. Mechanisms of Action of Bcl-2 Family 
Proteins. Cold Spring Harb Perspect Biol. 2013;(5):1-21. 
doi:10.1101/cshperspect.a008714. 
81.  Bhola PD, Letai A. Mitochondria-Judges and Executioners of Cell Death Sentences. 
Mol Cell. 2016;61(5):695-704. doi:10.1016/j.molcel.2016.02.019. 
82.  Happo L, Strasser A. BH3-only proteins in apoptosis at a glance. J Cell Sci. 
2012;125:1081-1087. doi:10.1242/jcs.090514. 
83.  Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 
protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 
2014;15(1):49-63. doi:10.1038/nrm3722. 
84.  Wei MC, Zong W, Cheng EH, et al. Proapoptotic BAX and BAK: A Requisite 
Gateway to Mitochondrial Dysfunction and Death. Science (80- ). 
2011;292(5517):727-730. doi:10.1126/science.1059108.Proapoptotic. 
85.  Scorrano L, Oakes SA, Opferman JT, et al. BAX and BAK Regulation of Endoplasmic 
Reticulum Calcium: A Control Point for Apoptosis. Science (80- ). 
2003;300(April):135-140. 
 66 
86.  Iurlaro R. Cell death induced by endoplasmic reticulum stress. FEBS J. 
2016;283:2640-2652. doi:10.1111/febs.13598. 
87.  Li J, Lee B, Lee AS. Endoplasmic reticulum stress -induced apoptosis: multiple 
pathways and activation of p53 -up-regulated modulator of apoptosis (PUMA) and 
NOXA by p53. J Biol Chem. 2006;281(11):7260-7270. doi:10.1074/jbc.M509868200. 
88.  Logue SE, Cleary P, Saveljeva S, Samali A. New directions in ER stress-induced cell 
death. Apoptosis. 2013;18(5):537-546. doi:10.1007/s10495-013-0818-6. 
89.  Puthalakath H, Reilly LAO, Gunn P, et al. ER Stress Triggers Apoptosis by Activating 
BH3-Only Protein Bim. Cell. 2007;129:1337-1349. doi:10.1016/j.cell.2007.04.027. 
90.  Yip KW, Reed JC. Bcl-2 family proteins and cancer. Oncogene. 2008;27:6398-6406. 
doi:10.1038/onc.2008.307. 
91.  Lagares-tena L, Mjiyad N El, Ramírez-peinado S, Alc F. 2-Deoxyglucose Induces 
Noxa-Dependent Apoptosis in Alveolar Rhabdomyosarcoma. Cancer Res. 
2011;71(21):6796-6807. doi:10.1158/0008-5472.CAN-11-0759. 
92.  Yamaguchi H, Wang H. CHOP Is Involved in Endoplasmic Reticulum Stress-induced 
Apoptosis by Enhancing DR5 Expression in Human Carcinoma Cells. J Biol Chem. 
2004;279(44):45495-45502. doi:10.1074/jbc.M406933200. 
93.  Gomez BP, Riggins RB, Shajahan AN, et al. Human X-Box binding protein-1 confers 
both estrogen independence and antiestrogen resistance in breast cancer cell lines. 
FASEB J. 2007:4013-4027. doi:10.1096/fj.06-7990com. 
94.  Szegezdi E, Macdonald DC. Bcl-2 family on guard at the ER. J Physiol Cell Physiol. 
2009;296:941-953. doi:10.1152/ajpcell.00612.2008. 
95.  White C, Li C, Yang J, et al. The endoplasmic reticulum gateway to apoptosis by Bcl-
XL modulation of the InsP3R. Nat Cell Biol. 2005;7(10). doi:10.1038/ncb1302. 
96.  Li G, Mongillo M, Chin K, et al. Role of ERO1-alpha–mediated stimulation of inositol 
1,4,5-triphosphate receptor activity in endoplasmic reticulum stress–induced 
apoptosis. J Cancer Prev. 2009;186(6):783-792. doi:10.1083/jcb.200904060. 
97.  Chernorudskiy AL, Zito E. Regulation of Calcium Homeostasis by ER Redox: A 
Close-Up of the ER/Mitochondria Connection. J Mol Biol. 2017;429(5):620-632. 
doi:10.1016/j.jmb.2017.01.017. 
98.  Zecchini E, Pinton P. Ca2+ transfer from the ER to mitochondria: when, how and why. 
Biochim Biophys Acta. 2010;1787(11):1342-1351. doi:10.1016/j.bbabio.2009.03.015. 
99.  Szado T, Vanderheyden V, Parys JB, et al. Phosphorylation of inositol 1,4,5-
trisphosphate receptors by protein kinase B/Akt inhibits Ca 2+ release and apoptosis. 
PNAS. 2008;105(7):2427-2432. 
100.  Smith TM, Hicks-berger CA, Kim S, Kirley TL. Cloning, expression, and 
characterization of a soluble calcium-activated nucleotidase, a human enzyme 
belonging to a new family of extracellular nucleotidases. Arch Biochem Biophys. 
2002;406:105-115. 
101.  Murphy DM, Ivanenkov V V, Kirley TL. Bacterial Expression and Characterization 
 67 
of a Novel, Soluble, Calcium-Binding, and Calcium-Activated Human Nucleotidase. 
Biochemistry. 2003;42:2412-2421. doi:10.1021/bi026763b. 
102.  Yang M, Kirley TL. Site-Directed Mutagenesis of Human Soluble Calcium-Activated 
Nucleotidase 1 (hSCAN-1): Identification of Residues Essential for Enzyme Activity 
and the Ca2+-Induced Conformational Change. Biochemistry. 2004;1:9185-9194. 
103.  Failer BU, Braun N, Zimmermann H. Cloning, Expression, and Functional 
Characterization of a Ca2+-dependent Endoplasmic Reticulum Nucleoside 
Diphosphatase. J Biol Chem. 2002;277(40):36978-36986. 
doi:10.1074/jbc.M201656200. 
104.  Faden M, Al-zahrani F, Arafah D, Alkuraya FS. Mutation of CANT1 Causes 
Desbuquois Dysplasia. Am J Med Genet. 2010;152(April):1157-1160. 
doi:10.1002/ajmg.a.33404. 
105.  Bertoli M, Chami M, Alanay Y, et al. Identification of CANT1 Mutations in 
Desbuquois Dysplasia. Am J Hum Genet. 2009;85:706-710. 
doi:10.1016/j.ajhg.2009.10.001. 
106.  Kim O, Nishimura G, Song H, et al. A Variant of Desbuquois Dysplasia Characterized 
by Advanced Carpal Bone Age, Short Metacarpals, and Elongated Phalanges: Report 
of Seven Cases. Am J Med Genet. 2010;(March):875-885. doi:10.1002/ajmg.a.33347. 
107.  Nizon M, Leonardis F De, Merrina R, et al. Further Delineation of CANT1 Phenotypic 
Spectrum and Demonstration of Its Role in Proteoglycan Synthesis. Hum Mutat. 
2012;33(8):1261-1266. doi:10.1002/humu.22104. 
108.  Balasubramanian K, Li B, Krakow D, et al. MED resulting from recessively inherited 
mutations in the gene encoding calcium-activated nucleotidase CANT1. 
2017;(May):2415-2421. doi:10.1002/ajmg.a.38349. 
109.  Hermans KG, Bressers AA, Korput HA Van Der, Dits NF, Jenster G, Trapman J. Two 
Unique Novel Prostate-Specific and Androgen-Regulated Fusion Partners of ETV4 in 
Prostate Cancer. Cancer Res. 2008;68(9):3094-3099. doi:10.1158/0008-5472.CAN-
08-0198. 
110.  Gerhardt J, Steinbrech C, Büchi O, et al. The Androgen-Regulated Calcium-Activated 
Nucleotidase 1 (CANT1) Is Commonly Overexpressed in Prostate Cancer and Is 
Tumor-Biologically Relevant in Vitro. AJPA. 2011;178(4):1847-1860. 
doi:10.1016/j.ajpath.2010.12.046. 
111.  Calì T, Fedrizzi L, Ottolini D, et al. Ca2+ -activated Nucleotidase 1, a Novel Target 
Gene for the Transcriptional Repressor DREAM (Downstream Regulatory Element 
Antagonist Modulator), Is Involved in Protein Folding and Degradation. J Biol Chem. 
2012;287(22):18478-18491. doi:10.1074/jbc.M111.304733. 
112.  Uccelletti D, Pascoli A, Farina F, et al. APY-1, a Novel Caenorhabditis elegans 
Apyrase Involved in Unfolded Protein Response Signalling and Stress Responses. Mol 
Biol Cell. 2008;19(April):1337-1345. doi:10.1091/mbc.E07. 
113.  Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time 
quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25(4):402-408. 
 68 
doi:10.1006/meth.2001.1262. 
114.  Zinchuk V, Zinchuk O. Quantitative Colocalization Analysis of Confocal 
Fluorescence Microscopy Images. Curr Protoc Cell Biol. 2008;(June):1-16. 
doi:10.1002/0471143030.cb0419s39. 
115.  Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the 
study of functionally distinct cancer subtypes. Cancer Cell. 2006;10(December):515-
527. doi:10.1016/j.ccr.2006.10.008. 
116.  Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. Breast 
Cancer Res. 2011;13:215-221. doi:10.1186/bcr2889. 
117.  Xing L, Hung M, Bonfiglio T, Hicks DG, Tang P. Breast Cancer : Basic and Clinical 
Research The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR 
by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer Basic 
Clin Res. 2010;4(35-41):35-41. 
118.  Mazumdar A, Poage GM, Shepherd J, et al. Analysis of phosphatases in ER-negative 
breast cancers identifies DUSP4 as a critical regulator of growth and invasion. Breast 
Cancer Res Treat. 2016;158(3):441-454. doi:10.1007/s10549-016-3892-y. 
119.  Jackisch C, Hahm HA, Tombal B, et al. Delayed Micromolar Elevation in Intracellular 
Calcium Precedes Induction of Apoptosis in Thapsigargin-treated Breast Cancer Cells. 
Clin Cancer Res. 2000;6(July):2844-2850. 
 69 
APPENDIX A – Chemicals 
Chemicals and Media Components  Supplier Company 
Acrylamide/Bis-acrylamide    Sigma, Germany 
APS       Amresco, USA 
Bradford solution     Biorad, USA 
BSA       Gemini, USA 
Chaps       Sigma, Germany 
DAPI       Life Technologies, USA 
Distilled water     Milipore, France 
DMSO       Sigma, Germany 
DMSO       AppliChem, Germany 
DMEM/F12      Thermo Fisher Scientific, UK 
EDTA       Riedel-de Haen, Germany 
EGTA       Riedel-de Haen, Germany 
ER-Tracker Red     Life Technologies, USA 
Ethanol      Merck, Germany 
FBS       Pan, Fermany 
Glycerol      Sigma, Germany 
Glycine      Molekula, UK 
HCl       Merck, Germany 
Isopropanol      Merck, Germany 
KCl       Amresco, USA 
KH2PO4      Riedel-de Haen, Germany 
Liquid nitrogen     Karbogaz, Turkey 
Methanol      Sigma, Germany 
MgCl2       Sigma, Germany 
Milk diluent concentrate    KPL, USA 
Milk powder (non-fat, dried)    AppliChem, Germany  
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Mito-Tracker Red     Life Technologies, USA   
Na2HPO4      Merck, Germany 
NaCl       Merck, Germany 
NaOH       Merck, Germany 
Paraformaldehyde     Sigma, Germany 
PBS       PAN, Germany 
Penicillin-Streptomycin    Life Technologies, USA 
phoSTOP phosphatase inhibitor   Roche, Germany 
Protease inhibitor cocktail tablet   Roche, Germany 
PVDF membrane     Roche, Germany 
Sodium Dodecyl Sulphate    Sigma, Germany 
TEMED      Sigma, Germany 
Thapsigargin      Sigma, Germany 
Tris       AppliChem, Germany 
Trypan Blue      NanoEnTek, Korea 
Trypsin-EDTA     PAN, Germany 
TritonX-100      Sigma, Germany 
Tween20      Sigma, Germany 
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APPENDIX B – Equipment 
 
Equipment      Supplier Company 
Autoclave      Hirayama, Hiclave HV-110, Japan 
Balance      Sartorius, BP221S, Germany 
Cell Counter      NanoEnTek, Korea 
Centrifuge Kendro Lab. Prod., Multifuge 3S-R, 
Heraeus, Germany 
 
Eppendorf, 5415D, Germany 
 
Eppendorf, 5424R, Germany 
 
Eppendorf, 5430R, Germany 
ScanSpeen Mini, Labogene, Denmark 
CO2 Incubator      Binder, Germany 
Computer Software     CoLocalizer Pro 3.0.2 
       GraphPad Prism 5 
       ImageJ 1.51w 
Deepfreeze                                                                  -80°C, Kendro Lab Prod., Heraeus  
Hfu486Basic, Germany 
 
-20°C, Bosch, Turkey 
Distilled Water     Millipore, Elix-S, France 
Gel Electrophoresis and Blotting System  Mini-PROTEAN Tetra Cell, Biorad, 
       Mini-PROTEAN 3 Cell, Biorad, USA 
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Heat Block      Bio TDB-100, Biosan SIA, Latvia 
Hemocytometer     Hausser Scientific,Blue Bell Pa.,USA 
Ice Machine      Scotsman Inc., AF20, USA 
Imaging System (Western Blot)   LAS4000 mini, Fujifilm, Japan 
Laminar Flow Kendro Lab. Prod., Heraeus, HeraSafe 
HS12, Germany 
Liquid Nitrogen Tank     Taylor-Wharton, 3000RS, USA 
Magnetic Stirrer VELP Scientifica, ARE Heating 
Magnetic Stirrer, Italy 
Microliter Pipettes     Gilson, Pipetman, France 
 
Eppendorf, Germany 
Microscope LSM 710, Confocal Laser Scanning 
Microscope, Zeiss, Germany 
Olympus CKX41, Japan 
Microscope Slides 0.17mm, Thermo Fisher Scientific,   
USA 
Microtiter Plate Reader     Microplate Reader 680, Biorad, USA 
pH meter      WTW, pH540 GLP MultiCal, Germany 
Power Supply      Biorad, PowerPac 300, USA 
 
Wealtec, Elite 300, USA 
Refrigerator      Bosch, Turkey 
Shaker-Rotater     Gyro-rocker SSL3, Stuart, UK 
 
IKA KS 260 Basic, USA 
 
Labquake, ThermoScientific, USA 
 
Spectrophotometer     ND-1000, Nanodrop, USA 
Thermocycler      LightCycler 480, Roche, Germany 
Vortex       Velp Scientifica, Italy 
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Water Bath      Huber, Polystat cc1, Germany 
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APPENDIX C – Solutions and Buffers 
0.1% Blocking solution (0.1% BSA) 
0.1 g BSA 
100 ml 1X PBS 
0.5% Triton-X100 solution 
250 μl TritonX-100 
50 ml 1X PBS 
1% Chaps buffer 
500 μl 1M MgCl2 
13.7 ml 1M NaCl 
1 ml 100 mM EDTA 
1 ml 100 mM EGTA 
1 g Chaps 
0.242 g Tris 
complete to 100 ml with dH2O  
add protease and phosphatase inhibitors 
4% PFA 
4 g Paraformaldehyde 
70 g dH2O 
200 μl 5M NaOH 
10 ml 10X PBS 
complete to 100 ml with dH2O 
10% APS 
0.1 g APS 
1 ml dH2O 
Mounting medium 
50% Glycerol in 1X PBS 
PBS (10X) 
80 g NaCl 
2.25 g KCl 
23.27 g Na2HPO4.12H2O 
2.05 g KH2PO4 
complete to 1000 ml with dH2O 
adjust pH to 7.4 
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Running buffer 
30.3 g Tris 
144.1 g Glycine 
10 g SDS 
complete to 1000 ml with dH2O 
adjust pH to 8.3 
Transfer buffer (10X-stock solution) 
144.2 g Glycine 
30.8 g Tris 
complete to 1000 ml with dH2O 
Transfer buffer (1X-working solution) 
70 ml 10X Transfer buffer 
140 ml Methanol 
490 ml dH2O 
Tris-HCl-SDS (pH:6.8) 
6.05 g Tris 
100 ml dH2O 
adjust pH to 6.8 with 1N HCl 
add 0.4 g SDS 
Tris-HCl-SDS (pH:8.8) 
91 g Tris 
500 ml dH2O 
adjust pH to 8.8 with 1 N HCl 
add 2 g SDS 
Western Blot blocking solution - 5% milk 
5 g non-fat dried milk 
100 ml washing solution 
Western Blot washing solution - PBS-Tween20 (PBST) solution (1X) 
100 ml PBS (10X) 
900 ml dH2O 
2 ml Tween20 
Western Blot primary antibody incubation solution 
3200 μl dH2O 
4 μg antibody 
400 μl milk diluent 
400 μl PBS-T 
Western Blot secondary antibody incubation solution 
1 μg antibody  
10 ml 5% milk 
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APPENDIX D – Molecular Biology Kits and Reagents 
Commercial Kit      Supplier Company 
Cell Proliferation Reagent WST-1     Roche, Germany 
Luminata Crescendo Western HRP Substrate  Millipore, USA 
RNeasy Mini Kit (74104)     Qiagen, Germany 
QuantiTect SYBR Green RT-PCR Kit   Qiagen, Germany 
QuantiTect Primer Assay Hs_CANT1_1_SG  Qiagen, Germany 
QuantiTect Primer Assay Hs_GAPDH_1_SG  Qiagen, Germany 
APPENDIX E – Antibodies 
Antibody / Catalog Number     Supplier Company  
Anti-CANT1 Monoclonal (C-3) /sc-515574   Santa Cruz Biotechnology 
  
Anti-β-Actin Monoclonal / 4967L    Cell Signaling Technologies 
Anti-Mouse HRP-conjugated / 7076    Cell Signaling Technologies 
Anti-Rabbit HRP-conjugated / 7074    Cell Signaling Technologies 
Alexa Fluor® 488 anti-mouse / A-11029   Thermo Fisher Scientific 
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APPENDIX F – ATCC Breast Cancer Cell Panel (30-4500K™) 
Cell Line ATCC Code 
184B5  ATCC CRL-8799 
AU-565  ATCC CRL-2351 
BT-20  ATCC HTB-19 
BT-474  ATCC HTB-20 
BT-483  ATCC HTB-121 
BT-549  ATCC HTB-122 
CAMA-1  ATCC HTB-21 
DU4475  ATCC HTB-123 
HCC38  ATCC CRL-2314 
HCC70  ATCC CRL-2315 
HCC202  ATCC CRL-2316 
HCC1187  ATCC CRL-2322 
HCC1395  ATCC CRL-2324 
HCC1419  ATCC CRL-2326 
HCC1428  ATCC CRL-2327 
HCC1500  ATCC CRL-2329 
HCC1569  ATCC CRL-2330 
HCC1599  ATCC CRL-2331 
HCC1806  ATCC CRL-2335 
HCC1937  ATCC CRL-2336 
HCC1954  ATCC CRL-2338 
HCC2157  ATCC CRL-2340 
HCC2218  ATCC CRL-2343 
Hs 578Bst  ATCC HTB-125 
Hs 578T  ATCC HTB-126 
MCF7  ATCC HTB-22 
MCF 10A  ATCC CRL-10317 
MCF 10F  ATCC CRL-10318 
MCF-12A ATCC CRL-10782 
MDA-kb2  ATCC CRL-2713 
MDA-MB-134-6  ATCC HTB-23 
MDA-MB-157  ATCC HTB-24 
MDA-MB-175-7  ATCC HTB-25 
MDA-MB-231  ATCC HTB-26 
MDA-MB-361  ATCC HTB-27 
MDA-MB-415  ATCC HTB-128 
MDA-MB-436  ATCC HTB-130 
MDA-MB-453  ATCC HTB-131 
MDA-MB-468 ATCC HTB-132 
SK-BR-3  ATCC HTB-30 
T47D  ATCC HTB-133 
UACC-812  ATCC CRL-1897 
UACC-893  ATCC CRL-1902 
ZR-75-1  ATCC CRL-1500 
ZR-75-30  ATCC CRL-1504 
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APPENDIX G – Protein Molecular Weight Marker 
 
Figure G.1. PageRuler™ Plus Prestained Protein Ladder (#26619), Thermo Scientific 
 
